IPhA Q2 Journal 2017

Page 1

2nd Quarter 2017 • www.ipha.org

Join Us For the


Joint Annual Conference Sept. 7–10, 2017

Marriott St. Louis Grand

IN THIS ISSUE COLUMNS 3 President's Perspective 5 Executive Director's Viewpoint 7 Local Association News 15 Pharmacy Time Capsule 17 From the Editor 18 Midwestern University 36 Rosalind Franklin University of Medicine and Science College 38 What's New With You 38 Words from Our Wise 40 Midwestern University 2017 Graduates 42 University of Illinois at Chicago College of Pharmacy Graduates 44 Chicago State University Graduates 45 Rosalind Franklin University and Roosevelt University 2017 Graduates 46 St. Louis College of Pharmacy Graduates 48 Southern Illinois University Edwardsville Graduates 52 Rx and the Law 54 IPhA Foundation 55 PAC IPhA Executive Committee Chairman of the Board Eric Bandy, RPh eric@bandys.biz President Ben Calcaterra, RPh ky_bjc@yahoo.com Vice President Laura Licari, PharmD llicari@hotmail.com President Elect Jessica Kerr, PharmD, CDE jekerr@siue.edu Treasurer David Mikus, RPh davetravel1@aol.com

FEATURED THIS ISSUE 8 NABP Re-elects Philip P. Burgess, MBA, DPh, RPh 10 FDA statement — new warnings about the use of codeine and tramadol in children & nursing 12 PMG Financial Forum 14 Can you guess who is in this Picture? 16 Welcome Aboard to New Members 24 IPhA/MPA Joint Annual Conference 28 IPhA/MPA Joint Annual Conference Schedule 29 IPhA/MPA Joint Annual Conference Registration 32 Pharmacy Crime 50 Harris-Stowe and St. Louis College of Pharmacy

4 Pharmacy Advocacy Fund 9 Join + Support your Local Associations 11 Illinois Professional Health Program 23 PAAS 30 IPhA & MPA Foundations Silent Auction 31 Wall of Wine 36 Smith Drug Company 37 IPhA Online Career Center 39 PACE Alliance 47 Lindsay Law 47 IPhA/MPA Joint Annual Conference 49 Pharmacists Mutual 51 Advertise Here 53 PTCB Back Cover APMS

Page 32

Page 10 IPhA Staff Executive Director Garth Reynolds, RPh greynolds@ipha.org Accounting Manager Erica Burris ericab@ipha.org Member Services Manager Kimberly Condon kimc@ipha.org Administrative Assistant Sandra Dial sandrad@ipha.org Director of Clinical Programs Starlin Haydon-Greatting, RPh starlin@ipha.org

Secretary Beaux Cole beauxcole@me.com

Illinois Pharmacists Association | 204 W Cook Street | Springfield, IL 62704 Phone: (217) 522-7300 | Fax: (217) 522-7349 Email: ipha@ipha.org | Website: www.ipha.org



MISSION STATEMENT: The Illinois Pharmacists Association is dedicated to enhancing the professional competency of pharmacists, advancing the standards of pharmacy practice, improving pharmacists’ effectiveness in assuring rational drug use in society, and leading in the resolution of public policy issues affecting pharmacists. VOLUME 80, NUMBER 2 (2nd Qtr 2017): The Illinois Pharmacist (ISSN 0195-2099) is published quarterly by the Illinois Pharmacists Association located at 204 W Cook, Springfield, IL 62704. Subscriptions are $200 per year. Periodical postage paid at Pontiac, IL and additional mailing offices. Postmaster: Send address changes to Illinois Pharmacist, 204 W Cook, Springfield, IL 62704 * Phone: (217) 522-7300 * Fax: (217) 522-7349. All contents ©2014 Illinois Pharmacists Association. STATEMENT OF PURPOSE: The Illinois Pharmacist is a forum for debate and new ideas regarding pharmacy in the State of Illinois. Its goals are to keep members informed on legislative and regulatory developments and pharmacy practice issues, to help members improve job performance by providing practical information and to inform members about Association activities. The opinions and positions expressed in articles contained in the Illinois Pharmacist are those of the authors and do not necessarily reflect the opinions and positions of the membership, officers, directors or staff of the Illinois Pharmacists Association. Illinois Pharmacist reserves the right to reject any advertising considered by management to be objectionable. Illinois Pharmacist also reserves the right to place the word “advertisement” on any ad it believes to resemble editorial material.


President’s Viewpoint

Fighting FOR THE PATIENT and Not the Profit


wning and managing a pharmacy in today's healthcare world has become exponentially more difficult in just the last decade. The enormous requirements we are forced to comply with come in a wide range from PBM contracts, Medicare standards, audits, technological advances, EQUIPP, Mirixa (I could go on and on). It is easy to get so sidetracked from continuously dealing with all these other spokes in the pharmacy wheel that we risk losing sight of the ultimate focus: our patients. This month my pharmacy team has sent in 5 audits, spent countless hours on EQUIPP data and Mirixa cases, scoured end of day reports for below cost reimbursement issues, addressed hundreds of scripts that were correctly filled but lacking details required by PBM contracts, and suffered a catastrophic computer failure. This was all time spent fulfilling the needs of the PBM’s and directly prevented me from spending this time serving my patients. If audits were looking for fraud, waste and abuse of the prescriptions for which they are paying I would be fine with working on audits, however today’s process allows for the full take back of the entire claim if a non-essential clerical error exists anywhere. This egregious practice forces the pharmacy staff to devote more attention to dotting i’s and crossing t’s than necessary instead

of focusing on getting the right medicine out the door and spending time counseling the patients. But, aren’t the programs designed to help patients worth the time spent on them? Well, we all know the current reimbursement rates for MTM services are not nearly the pharmacist wages spent to complete the service, even though it was devised with the best of intentions. And, likewise, EQUIPP has its heart in the right place to help patients become more adherent and catch some missing meds, but it has turned into a source of financial penalties rather than the intended purpose of rewarding the pharmacies that are excelling. My fear is that pharmacies will be blackmailed into fraudulently filling refills regardless of patient need because the missed copays are much cheaper than the financial penalties the PBM’s are assessing for not hitting the benchmarks. This is a real possibility for the near future unless the free reign of PBM’s is kept in check. Thankfully, we will be hearing from Zac Renfro with Pharmacy Quality Solutions (PQS), the creators of the EQUIPP platform, at conference in September to hear all about the measures, how they are derived, how we can best manage our workflows to incorporate the measures and impact our overall scores. We need to advocate for our patients. This involves standing up to the ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

IPhA President Ben Calcaterra

PBM’s to realign their focus into patient positive programs instead of sneaky pharmacy negative programs. We need PBM legislation in this state like Senate Bill 1844 to allow prorated med synching of patients and audit reform. When it gets called we need your voice to hold back the tyranny that is being imposed on pharmacies with little to no leverage against harsh contracts in a take-itor-leave-it methodology. We need to be rewarded by sharing in the huge financial bonuses the PBM’s gain from increasing their star ratings which we helped bolster instead of fearing the thousands of dollars taken away because a patient is allergic to a statin and the PBM only sees a missed fill opportunity. We need the continued help of NCPA and other national organizations to continue the fight against unethical DIR fees so we know what we are actually paid for each transaction . We need better reimbursement for claims so that we can spend time with our patients and make sure they are being adequately taken care of, and be paid for our cognitive services (ask about I-CPEN) so we can focus on the future of pharmacy today. Help us fight for your patients’ health! 3

IPhA needs your financial support to continue monitoring legislation and advocating for pharmacy. Please consider contributing today!

Thank you

to the following donors as of 2nd Quarter 2017! Tony Budde Byron Berry

Gary Ceretto John Groesbeck

Jonathan Lehan Rodney Brent

I am proud to support the Illinois Pharmacy Advocacy Fund!


(as you wish name to appear in the acknowledgement of your contribution) Address: Phone: Email:

 If needed, I am willing to contact my state legislator to be an advocate for pharmacy in Illinois!

.............................................................................................................................................. Pledge Information:  Enclosed is my contribution of:  $2,000

 $1,000

 $500

 Other $__________

 I would like to contribute $_______ on a monthly basis until I notify IPhA to discontinue.  Please charge my credit card $_______ on the 15th of each month for one year.

................................................................................................................................. Payment Information:  Check payable to Illinois Pharmacists Association enclosed  Please charge my credit card:  Visa

 MasterCard

Card #: _____________________________________

CVV: _____________

 American Express

 Discover

Exp Date: ____________________________

Signature: _____________________________________________________

.............................................................................................................................................. Please mail or fax this page with your payment to: Illinois Pharmacists Association  204 West Cook St  Springfield IL 62704-2526  Fax 217-522-7349



Executive Director’s Viewpoint

2017 Spring Session

of the General Assembly and Regulatory Summary The following is a summary of pending pharmacy legislation. The Governor has not acted on any of the following bills; but these bills have passed both the Senate and the House, as of July 23, 2017.

HB3462 – Pharmacy Practice Act: Effective upon becoming law (Pending) Sponsor: Representative Michael Zalewski (D-Riverside) • Renews and Extends the Pharmacy Practice Act until January 1, 2020; • Various technical and terminology updates to the Pharmacy Practice Act; • Updates the definitions of “Electronic Transmitted Prescription” and “Address of Record”; • Adds the definition of “Email Address of Record” • Provides that applicants and licensees will keep the Department informed of a valid address and email address of record; • Creation of a Collaborative Pharmaceutical Task Force charged with discussing advancements of pharmacy practice and the needs of patients, pharmacies, pharmacists, and pharmacy technicians. This Task Force shall produce recommendations by September 1, 2019 and the Department will propose rules for adoption, based on the recommendations, by November 1, 2019; • Minimum number of pharmacy compliance investigators was removed; • Adds Confidentiality section protecting information gathered during an examination or investigation; • Makes the Citation Program for minor violations permanent.

IPhA Executive Director Garth K. Reynolds, BSPharm, RPh

SB317 – Alpha-Hydroxyprogesterone Caproate: Effective – 01/01/2018 (Pending) Sponsor: Senator John Mulroe (D-Chicago) • Amends the Pharmacy Practice Act, specifically the definition of the “Practice of Pharmacy” and would allow pharmacists with appropriate training to administer alpha-hydroxyprogesterone caproate pursuant to a prescription order.

SB636 – Dialysate: Effective upon becoming law (Pending) Sponsor: Senator Terry Link (D-Gurnee) • Amends the Pharmacy Practice Act ‘Exemptions’ Section; Provides that the Act shall not apply to, or in any manner interfere with, the sale or distribution of dialysate or devices necessary to perform home peritoneal renal dialysis for patients with endstage renal disease so long as certain conditions are met; The dialysate or devices may be held at a manufacturer or manufacturer’s agent, which is properly registered; • Dialysate or devices can only be delivered to the patient upon receipt of physician’s prescription by a licensed pharmacy (and processed in accordance with the Act); • Does not include any other drugs for peritoneal dialysis, except dialysate.



Executive Director’s Viewpoint (continued) • Medications can safely be utilized into a short-fill scenario to achieve synchronization; • Medications do not have special handling or sourcing requirement under the policy; • Interruption of therapy might reasonably produce • Policy shall allow a prorated daily cost-sharing rate to undesirable consequences or cause patient suffering; any medication dispensed; • Pharmacy previously dispensed or refilled a • No dispensing fees shall be prorated, and dispensing prescription from the prescriber for the same fees shall be based on number of prescriptions filled patient and medication; or refilled. • Not for a controlled substance; • Inform the patient or the patient's agent at the time of In addition to the above legislation, IPhA was actively on numerous bills. Here are some of the highlights: dispensing that prescriber authorization is required for future refills; Support • Emergency dispensing is documented in the patient's HB2531 – removes the now defunct language requiring pharmaceutical manufacturers to report bioequivalence prescription record and the pharmacist informs the information to Public Health for the Illinois Formulary. prescriber of the emergency refill; (Sent to Governor) • Emergency supply must be limited to the amount needed for the emergency period; HB3161 – Dept of Human Services to create a public • Total amount dispensed shall not exceed a 30-day education website focused on heroin and prescription supply. opioid abuse. (Sent to Governor)

SB1790 – Emergency Refill: Effective upon becoming law (Pending) Sponsor: Senator Steve Stadelman (D-Rockford)

SB1944 – Hypodermic Syringes and Needles: Effective – 01/01/2018 (Pending) Sponsor: Senator Chris Nybo (R-Lombard) • Increases the limit from 20 to 100 hypodermic syringes or needles to a person without a prescription being required; • Reduces barriers for patients to access and obtain hypodermic syringes and needles, without the need for a prescription and increased health expenditures for a medical visit; • Clarifies that electronic prescriptions may be used for hypodermic syringes and needles; • Increases access to safe and clean needles to individuals who may utilize illicit substances.

HR100 – directs the Audit General to conduct an audit

of the Medicaid Managed Care Organizations, including comparing Managed Medicaid versus Fee-For-Services. (Resolution Adopted)


HB3388 – would have required Home Medical

Equipment Providers and Pharmacies that dispense pressurized oxygen to provide the patient’s address and personal information to the local fire or emergency departments or protection district. (Held in Committee) IPhA believes that this bill would be a violation of a patient’s protected health information.

SB1607 – would require prescribers to check

the Prescription Monitoring Program each time a

HB2957 – Medication Synchronization: Effective controlled substance would be written. The bill would upon becoming law (Pending) require pharmacists to obtain a signature to dispense a Sponsor: Representative Laura Fine (D-Glenview) controlled substance if the patient has been identified by the PMP on a 3:3:1 (3 Pharmacies or 3 Prescribers in 1 • Allows for the coordination of two or more Month) report. IPhA and ISMS (Med Society) worked medications for one or more chronic conditions; with the sponsor to amend the bill to: Prescribers • Synchronization shall be allowed at least one shall attempt to check the PMP and document when occasion per insured per year; providing an initial C-II opioids prescription. (Except • Medications must be covered and considered for oncology, palliative care, 7-days or less supply.) The maintenance medications under the policy; pharmacists responsibilities have been amended to that • Medications are not Schedule II, III, or IV; 6 ILLINOIS PHARMACISTS ASSOCIATION VOL. 80 - NO. 2 (2 QTR 2017) •





IPhA Pharmacy Legislative Day — March 15, 2017

Group 19 consisted of Coordinators Anthony Budde (Highland) & Stephen Peipert (Edwardsville), Pharmacists Eric Bandy (Salem), Mark Timmermann (Breese), & Pharmacy Students Keidrah Hardiek (Newton), Kenley Masterson (Carmi), Lauren McCulley (O’Fallon), & Callie Schwartzkopf (Nashville). We met with Senators Kyle McCarter & Dale Righter.

We met with Representatives Charles Meier, & John Cavaletto. We attempted to meet with Rep David Reis.

MEPA’s 58th Annual Scholarship Awards Banquet …

…was held on April 1, 2017 at the LeClaire Room at the NO Nelson Center. The center is Lewis & Clark Community College’s Edwardsville campus. Guests included IPhA President Ben Calcalterra, Executive Director Garth Reynolds, Region 7 Director Harry Zollars, Community Pharmacy Practitioner Section Chair Micah Howell, & Past Presidents Steve Clement, Gary Ceretto, & Tony Budde. St Louis College of Pharmacy attendees included Dr Bruce Canady, Jerry Thomas, & students. SIUE School of Pharmacy attendees included Dr Walter Sigmamga & students. Bella Milano catered a wonderful meal and the “Piano Man’s” performance was outstanding.

Executive Director’s Viewpoint (continued) if a prescriber is send a 3:3:1 report than the pharmacy should also be sent a copy. (Bill in House Healthcare Licenses Committee) IPhA is still in opposition until all parties are in agreement.

SB2011 – would limit opioid prescriptions to a 7-day

supply or less for any patient 18 years or younger. Initial prescription must be 7-days supply for 18 years or older. The bill would allow a pharmacist to partial dispense a C-II prescription (which is already allowed under law). (Held in Committee) IPhA is still in opposition until all parties are in agreement. Throughout the spring, IPhA worked diligently on the upcoming patient counseling mandate, from the Dept of Financial and Professional Regulation. The upcoming mandate is more amenable than where we started. IPhA and other pharmacy stakeholders negotiated to remove measures that would have increased the burden on the delivery of patient care. These negotiations were in addition to the extensive effort on HB2392 has discussed in detail in my last article (Anatomy of a Bill).

This spring and now summer, IPhA has been engaged with HFS on the upcoming required implementation of the Federal Covered Outpatient Drug rule. This rule would require HFS to pay pharmacies a Professional Dispensing Fee, instead of a traditional dispensing fee. IPhA has proposed an increase to a Professional Dispensing Fee of $10.66 based on a national research survey conducted by NCPA and NACDS. In addition, IPhA has provided comments and testimony (to the General Assembly) on the current status of the Managed Medicaid program and HFS’s proposal to expand this program to all 102 counties. Even with the State Budget issues hanging over the General Assembly, this session, IPhA has been very active working on the above bills and our legislative initiatives to move pharmacy forward and to protect your practices.



For Immediate Release Wednesday, May 24, 2017 Media Contact: Larissa Doucette

847/391-4405; help@nabp.pharmacy

NABP Re-elects Philip P. Burgess, MBA, DPh, RPh, to Serve as Member of Executive Committee at Association’s 113th Annual Meeting MOUNT PROSPECT, IL — Philip P. Burgess, MBA, DPh, RPh, was re-elected to serve a three-year member term, representing District 4, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 113th Annual Meeting, May 20–23, 2017, in Orlando, FL. Mr. Burgess has been a member of the Illinois State Board of Pharmacy since 2002 and has served five terms as chair of the Board. As president of Philip Burgess Consulting, LLC, in Chicago, IL, he assists health care clients with regulatory issues and implementing technology to improve patient care. Prior to his consulting role, Mr. Burgess spent 40 years in a variety of roles at Walgreen Co, including National Director of Pharmacy Operations and National Director of Pharmacy Affairs. An active member of NABP, Mr. Burgess has served on many of the Association’s task forces and committees, including the Task Force on the Regulation of Telepharmacy Practice, the Task Force on Drug Return and Reuse Programs, the Committee on Constitution and Bylaws, and the Committee on Law Enforcement/Legislation. In addition to serving as a Board member, Mr. Burgess has contributed his expertise to several Illinois State


committees, including the Illinois Health Information Exchange Advisory Committee, the Illinois Prescription Monitoring Program Advisory Committee, and the Illinois Office of Health Information Technology. At the national level, he was a member of the Pharmacy e-Health Information Technology Collaborative, served as chair of the Pharmacy Technician Certification Board Policy Council, and served on the Presidential Advisory Council on HIV/AIDS during the Clinton and Bush administrations. Mr. Burgess is an active member of several other pharmacy organizations. He was named the 2017 Honorary President of the American Pharmacists Association. Mr. Burgess has served as president of the Community Pharmacy Foundation’s Board of Trustees since its inception in 2002. In 2006, Mr. Burgess received the Harold W. Pratt Award, the lifetime achievement award presented by the National Association of Chain Drug Stores. Additionally, he is on the editorial advisory board for Drug Topics magazine. Mr. Burgess earned his bachelor of science degree in pharmacy from the University of Tennessee, and his master of business administration degree from the University of Chicago. NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.



See calendar of upcoming events on www.IPhA.org homepage for events.

Assn. of Indian Pharmacists in America

Lithuanian Pharmacists Assn.

Central Illinois Pharmacists Assn.

Metro-East Pharmacists Assn.

Harish Bhatt, President (815) 725-1102 harishbhatt@gmail.com Vacant, President

Champaign Area Pharmacists Assn. Rick Ingram, President 217-469-2007 mowog1@aol.com

Birute Apke, Joe Kalvaitis Co-Presidents birute.apke@gmail.com pharmjoe@hotmail.com Anthony Budde, Executive Secretary (618) 978-3520 budde76@charter.net

National Pharmacists Assn.

Chicago Pharmacists Assn.

Stephanie Hasan, Executive Director (773) 643-4200, info@cpha1922.com

Du Page County Pharmacists Assn. Ron Grossmayer, President (630) 881-3582 dupagepharmacists@gmail.com

Thomas Hanson, President (847) 658-2904 rphth@msn.com

North Suburban Pharmacists of Chicagoland Gary Frisch, President info@nspharmacists.org www.nspharmacists.org

Polish American Pharmacists Assn.

East Central IL Pharmacists Assn. Charles Luchtefeld, President (217) 347-1343 cluckyrph@yahoo.com

Bozena Karwowska, President (847) 772-7661, bozenkarph@comcast.net

Quad City Area Pharmacy Assn.

Far Southern Pharmacists Assn.

Kellie Byrd, President 2pharmhawks@gmail.com

Gateway East Pharmacy Assn.

Moira Maroney, President (708) 638-4853 sspa2006@yahoo.com

Illinois Valley Pharmacists Assn.

Thomas Blasdel, President (618) 895-2844 shoecreek@gmail.com

Jamie Kirkpatrick, President (618) 985-2441 jamiekirkpatrick76@hotmail.com

South Suburban Pharmacists Assn.

Southeastern Pharmaceutical Assn.

Gary Ceretto, President (618) 444-0431 cerettorx@aol.com

Donna Morscheiser, President (815) 224-4555 mohouse5@comcast.net

Springfield Pharmacists Assn. Preeteka Dhamrait, President preeteka@aol.com

Korean Pharmacists Assn. of Chicago Jane Hyonchu Lee, President (773) 319-6547 kaphachicago@gmail.com

T h e Vo i ce f o r P h ar macy i n I l l i n o i s T M



FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research on,

NEW WARNINGS about the use of

codeine and tramadol in children & nursing


he health and safety of children is a top priority at the FDA, which is why today we are requiring a series of changes to the labeling of two types of opioid medications in order to help better protect children from serious risks associated with these medicines — codeine (found in some prescription pain and cough medicines and some overthe-counter cough medicines)


and tramadol (found in some prescription pain medicines). We are requiring these changes because we know that some children who received codeine or tramadol have experienced life-threatening respiratory depression and death because they metabolize (or break down) these medicines much faster than usual (called ultra-rapid metabolism), causing dangerously high levels

of active drug in their bodies. This is especially concerning in children under 12 years of age and adolescents who are obese or have conditions that may increase the risk of breathing problems, like obstructive sleep apnea or lung disease. Respiratory depression can also occur in nursing babies, when mothers who are ultra-rapid metabolizers take these types of medicines and pass it along to their children through their breast milk.


This isn’t the first time we have taken action on codeine to better ensure the safety of our children. Since 2013, prescription codeine labeling has contained a Boxed Warning and Contraindication for children up to age 18 years of age regarding the risk of life-threatening respiratory depression following the use of codeine for pain management after the removal of the tonsils (tonsillectomy) and/ or adenoids (adenoidectomy). Now, labels for both codeine and tramadol are being updated to include additional Contraindications and Warnings; among the updates are Contraindications for use of codeine or tramadol in all children younger than 12 years of age, warnings about their use in children 12-18 years of age with certain medical conditions, and a stronger warning recommending against their use in nursing mothers. In addition to these labeling changes, labeling for tramadol-containing products will also get a Contraindication for post-operative pain management in children up to age 18 years of age who have undergone tonsillectomy and/or adenoidectomy, which is already in labeling for codeine products.

The FDA, an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332)

We urge health care providers, stakeholders and the public to read the Drug Safety Communication that we issued today, which provides more detailed information regarding the new Warnings and Contraindications, and the data that informed them. We also encourage parents to review the ingredients of pain medicines to see whether they include codeine or tramadol, and cough medicines to see if they contain codeine. It’s also important to check non-prescription cough and cold medicines that may be sold over the counter, as some of these medicines also include codeine. In all cases, if the medicine contains codeine or tramadol, parents should consult a health care provider before giving their children the medicines or taking them when nursing. We understand that there are limited options when it comes to treating pain or cough in children, and that these changes may raise some questions for health care providers and parents. However, please know that our decision today was made based on the latest evidence and with this goal in mind: keeping our kids safe. ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG



This series, Financial Forum, is presented by PRISM Wealth Advisors, LLC and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community.

Could You Improve Your Personal Finances Today? Simple decisions & new habits might lead you toward a better financial future.


n life, there are times when simple decisions can have a profound impact. The same holds true when it comes to personal finance. Here are some simple choices you could make that may leave you better off financially — in the near term, the long term, or both. Use less credit. Every time you pay with cash instead of credit, you are saving pennies on the dollar – actually, dimes on the dollar. At the start of December, the average “low interest” credit card in America charged users 12.45%, the average cash back card 17.15%. If you want to see your bank balance grow, try consistently paying in cash. There is no need to pay extra money when you pay for something.1 Set up automated contributions to retirement plans & investment accounts. By automating your per-paycheck salary deferrals to your workplace retirement plan or your IRA, you remove the chore (and the psychological hurdle) of having to make lump-sum contributions. You can bolster invested assets with regular


inflows of new money, without even thinking about it. Often, arranging these recurring account contributions takes 20 minutes or less of your time.2 Bundle your insurance. Many insurers will give you a discount if you turn to them for multiple policies (home and auto, possibly other combinations). This may help you reduce your overall insurance costs. Live somewhere less expensive. Sure, it takes money to move, but that one-time cost might be worth absorbing, especially if you can perform your job anywhere. A look at the December United States Rent Report at ApartmentList. com reveals that the median rent for a 1-bedroom apartment in Los Angeles is $1,900. The median rent for a 1-bedroom apartment in Spokane is $630. What is the median rent for a 2-bedroom apartment in Boston? $3,200. How about in Fayetteville, North Carolina? $700.3 Look into refinancing your largest debts. Perhaps your student loans could be consolidated. Perhaps you could qualify for a refi on your mortgage


(while rates are still low). Both of these moves could free up money and leave you with more financial “breathing room” each month. Spend less money on “stuff” and more money on yourself. Many people associate possessions with well-being – the more “toys” you have, the richer your life becomes. That kind of thinking can quickly put you deep in debt. You may find yourself living on margin as your “toys” depreciate. A wise alternative: pay yourself first and direct more of your income into retirement or savings accounts. Or if you like, use some money you would normally spend on creature comforts to attack

your debt. Instead of simply entertaining yourself today, make money moves on behalf of your financial future. Too many people give their financial future little thought, and they may be in for a shock when they reach retirement age. We all want to splurge now and then, but try spending money on memorable experiences instead of flashy items – you may find the former many times more valuable than the latter. Forgo several purchases a month and see what happens. A recent SunTrust bank survey found that roughly a third of U.S. households earning $75,000 or more live paycheck to paycheck. Earlier this year, Money noted that the average household

credit card balance was nearly $16,000. In short, people are spending too much.4 Some expenses are obligatory, others spur-of-the-moment and unexamined. Pause and think before you buy something; do you really need it? If you separate your needs from your wants and say no to several of them, you may find yourself living a simpler life with less debt and more cash. Spend less than what you make, invest and save some of the difference — this is the classic path toward improving your financial situation.

Pat Reding and Bo Schnurr may be reached at 800-288-6669 or pbh@berthelrep.com. Registered Representative of and securities and investment advisory services offered through Berthel Fisher & Company Financial Services, Inc. Member FINRA/SIPC. PRISM Wealth Advisors LLC is independent of Berthel Fisher & Company Financial Services Inc.

This material was prepared by MarketingLibrary.Net Inc., and does not necessarily represent the views of the presenting party, nor their affiliates. All information is believed to be from reliable sources; however we make no representation as to its completeness or accuracy. Please note - investing involves risk, and past performance is no guarantee of future results. The publisher is not engaged in rendering legal, accounting or other professional services. If assistance is needed, the reader is advised to engage the services of a competent professional. This information should not be construed as investment, tax or legal advice and may not be relied on for the purpose of avoiding any Federal tax penalty. This is neither a solicitation nor recommendation to purchase or sell any investment or insurance product or service, and should not be relied upon as such. All indices are unmanaged and are not illustrative of any particular investment 1bankrate.com/finance/credit-cards/current-interest-rates.aspx




3apartmentlist.com/rentonomics/national-rent-data/ 4time.com/money/4320973/why-you-are-poor/

[12/1/16] [6/6/16]



Can you guess who is in this Picture? Answer on page 16



Time Capsule


Dennis B. Worthen, PhD, Cincinnati, OH


• Oncologic pharmacy recognized as a specialty by BPS. • Pharmacy sales in the US totaled approximately $77.8 billion dollars. This expanded to almost $154 billion in 2002.

One of a series contributed by the American Institute of the History of Pharmacy, a unique non-profit society dedicated to assuring that the contributions of your profession endure as a part of America’s history. Membership offers the satisfaction of helping continue this work on behalf of pharmacy, and brings five or more historical publications to your door each year. To learn more, check out: www.aihp.org


• Drug Intelligence, later retitled to Drug Intelligence and Clinical Pharmacy and more recently Annals of Pharmacotherapy, inaugurated by editor and founder Donald Francke.


• Formation of the Utah Pharmacists Association


• American Society of Hospital Pharmacists (ASHP), now the American Society of Health-System Pharmacists, formed with 153 charter members.



to the following

NEW MEMBERS that joined the Association Jan 1 2017 — March 31st 2017

Academic Dues Members Bedrija Nikocevic Kilinyaa Cothran

New Practitioner Members Daniel McLawhorn Sheyma Hashmi Amanda Daniels Lauren Cope Kerry Otero Sara Schulz Kelsey Frichtl

Out of State Members Carla Vinson Stacy Doyleg

Regular Members

Retired Members

David Mankoff Jerrod Brown Carrie Cafferty Timothy Hipp Megan Kenkel John Brackney Brett Gordon Jennifer Howard Omolola Ajose Amy Stachowiak Zinah Fathi Anna Marie Kondic Nathan Vorac Lynda Minor Charles Karwowski James Scanlon Suhani Shah Victoria Ramonis-Rafacz Tiajuana Dixon Kit Moy Tony Bono Rina Soni Ogechi Orjis

William Scharringhausen

Technician Members William Connor Steve Heyder Courtney Herr Kristine Vankuiken

Can you guess who is in this Picture?

(Left to Right): John Watt, Roger Cain (Former Executive Director), Jack Hill, Ray Cicci, Ohil Ludwig 16


From The Editor

National Health Insurance? I am conflicted.

IPhA Editor

Jeffery Ellis, RPh

On the one hand, I see the point in we don’t want the heavy hand of the government (mostly the federal govt) dictating the diagnosis and treatment of my healthcare. It is a sacred trust that only my doctor and I should determine what is best for me and my health.

ASIDE: Of course, as a pharmacist, I have seen some

of these treatment plans, especially by skin and eye doctors, that I think are absolutely insane (I call and say the patient is objecting to paying $350 for the latest and most expensive steroid eye drop and they immediately switch to prednisolone 1%!) Don’t even ask the doctor, it is on their cheat pad. If the most expensive and latest steroid eye drop is the therapeutic breakthrough necessary for saving the vision of the patient, then use it no matter what the cost. Sell the car if necessary to save the vision! Cost is no consideration! This is eyesight we are discussing! Conversely, if it is not necessary, lead with prednisolone. Vision is very important for both the rich and the poor.) Someone needs to get a grip on these crazy doctors and their prescribing habits and the government seems to be the only one who could possibly do it. Now we are back to the first paragraph.

BACK TO THE POINT. What really concerns me about the government in charge of healthcare is lack of infrastructure spending. I swear the state of Illinois uses a 1987 DOS computer to administer their programs. (OK, a slight exaggeration). The government doesn’t want to spend dollars to upgrade. (If you are Republican, in the next sentence, replace Republicans and Bush with Democrats and Obama.) I blame the Republicans and their obsession with reducing taxes for

the rich. And George W. Bush. (I know, I know. I have a blind spot there as I blame those two for everything.) And what is the deal with that 4 Rx per 30 days limit? Why 4? Why not 3 or 5? Seems very arbitrary. So, we all hate the government and their wild, uncontrolled spending. That’s a given. The alternative we have landed on is having the heavy hand of faceless corporations and $30 million dollar CEO’s dictating the diagnosis and treatment of my healthcare. This is an improvement? These faceless corporations are only interested in the bottom line. The next quarter’s profits. And shareholders, etc. (In their defense, I believe they are required by law to do so.) Theoretically, the government is not interested in making a profit and is in it only for the benefit of their constituents. (I will stop and give you a moment here to stop laughing.)

Hopefully, you see my conflict.

The underlying problem is the insurance cartel. Unfortunately, I have no better solution. Who, besides the government, is in any position to get a grip in the insurances? At least with the government I can call Adam Kinsinger (my US Rep. For now.) and complain.

Who do I call at Blue Cross?! I am conflicted.


Jeff Ellis, R.Ph. 17

Midwestern University

Impact of Pharmacist Comprehensive Medication Reviews on Adherence Rates Elizabeth Van Dril, PharmD Midwestern University Chicago College of Pharmacy Christie Schumacher, PharmD, BCPS, BCACP, BC-ADM, CDE (Corresponding Author) Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Abstract


The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) has provided financial opportunities to develop medication therapy management (MTM) services in various pharmacy practice settings and incentivized pharmacists to conduct comprehensive medication reviews (CMRs). Health plans have been attempting to improve adherence through MTM services in hopes to identify and reduce the rates of nonadherence among chronic disease state medication users. This article reviews the question of whether CMR completion improves medication adherence.


Several studies have evaluated adherence to chronic disease state medications among Medicare beneficiaries; however, evidence of the positive impact CMRs delivered by community pharmacist have on medication adherence rates is 18

limited. Overall, evidence for the impact of CMR completion on medication adherence rates seems to be inconsistent and lacking.


While measuring the impact of CMR completion on medication adherence provides evidence to health plans of pharmacists’ contributions to the improvement of their performance measures and overall star ratings, evidence of higher quality care ultimately comes in the form of improved health outcomes. An increase in adherence has been shown to contribute to improved health outcomes and lower healthcare costs; therefore, studying whether CMR completion contributes directly to these measures may be more effective in demonstrating the worth of pharmacists’ care rather than measuring the effect on adherence alone. True impact of pharmacists’ care by CMR completion will be shown by measuring health outcomes and overall costs of care in recipients

of these MTM services and is an area of opportunity for further investigation to demonstrate the value of the pharmacist in new healthcare initiatives.


Adherence, medication therapy management, comprehensive medication reviews, disease management, chronic disease, community pharmacy


In 2003, the establishment of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) required that prescription drug plans (PDPs) and Medicare Advantage prescription drug (MA-PD) plans offer medication therapy management (MTM) services to all eligible beneficiaries.1 This act provided new financial opportunities to develop MTM services in various pharmacy practice settings and incentivized pharmacists to conduct comprehensive medication reviews (CMRs).1 In 2007, the


Medicare star rating system, created by the Centers for Medicare & Medicaid Services (CMS), was implemented in an effort to define, measure and incentivize healthcare based on quality.2 Additionally, in 2012, weighted star rating performance measures were introduced to focus efforts on improving clinical outcomes and reducing healthcare costs.2 Of the ten triple-weighted performance measures, eight are directly and indirectly related to medication therapy, and therefore, can be influenced by pharmacists collaborating with payers to provide interventions that improve the quality of care.2 Three of those measures that pharmacists have the ability to impact are directly related to drug therapy adherence.2 These include medication adherence for antihypertensive agents, specifically renin-angiotensin system (RAS) antagonists, oral antidiabetic medications and HMG-CoA reductase inhibitors, which are more commonly known as statin medications.2 The Pharmacy Quality Alliance (PQA), an organization that collaboratively develops strategies for measuring performance information related to medication use to promote higher quality care, recommends the metric Proportion of Days Covered (PDC) as the preferred measure of adherence.3

This recommendation stems from the idea that PDC is a more conservative estimate of adherence compared to alternatives, such as Medication Possession Ratio (MPR).3 The PDC is the proportion of days in a measurement period “covered” by prescription claims for the given medication or another in its therapeutic class.3 In contrast, MPR is defined as the sum of the days' supply for all fills of a given medication class in a specified time period, divided by the number of days in that time period.3,4 PDC is preferred because it avoids double counting in situations where refills may overlap, and according to the PQA, a PDC of greater than 80% equates to high adherence to the medication of interest.3,4 Health plans have been attempting to improve adherence through MTM services in hopes to identify and reduce the rates of nonadherence among chronic disease state medication users. Since a plan’s star rating has a substantial impact on beneficiary enrollment, small improvements in quality metrics can translate to significant positive effects on star ratings and therefore, the financial sustainability of third party payers.2 Intensive efforts have been made to improve those pharmacy-related, triple-weighted performance measures, and therefore, special attention to improving adherence for hypertension (HTN), diabetes ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

(DM) and cholesterol management medications has been a large focus of third party payers through the delivery of CMRs and targeted intervention programs (TIPs).2 This review provides a summary of the literature available on CMRs and adherence rates and demonstrates the need for more robust studies to evince the positive impact pharmacists can have on CMRs to further justify the value of the pharmacist’s role in health care reform. Summary

Effect of CMR Completion on Adherence Rates

Several studies have evaluated adherence to chronic disease state medications among Medicare beneficiaries; however, evidence of the positive impact CMRs delivered by community pharmacist have on medication adherence rates is limited. Historically, studies have had variances in the definitions of MTM services, which may or may not include CMRs, and have examined medication adherence only for specific disease states. These studies have shown a wide range of impact on adherence rates depending on the disease state and degree of intervention. The following is a chronological review of the progression of literature measuring the impact of completed CMRs on patients’ medication adherence. 19

A retrospective, cohort analysis by Branham et al. was conducted to determine if community pharmacist-provided MTM improves medication adherence among Medicare patients.5 The study took place at three independent community pharmacies in North Carolina and included 97 Medicare Part D beneficiaries with one or more chronic disease states who participated in a CMR between October 2007 and April 2008.5 Investigators measured the change in adherence by a prepost comparison of the PDC for all chronic disease medications based on prescription refill history 6 months before and after the documented date of the CMR service.5 Results of the study demonstrated that most patients were adherent to chronic disease medications before and after receiving a CMR.5 In the 6 months prior to receiving the CMR, patients’ average PDC was 87.2%, whereas in the 6 months following the CMR, average adherence to all chronic medications improved to 88.3%.5 The increase in mean PDC between the pre-CMR and post-CMR groups of 1.25% was not statistically significant (p=0.43).5 A subgroup analysis of patients taking medications for cholesterol management, gastroesophageal reflux disease, thyroid disorder and benign prostate hyperplasia 20

demonstrated improved adherence following a CMR with an increase mean PDC of 3.5%, 3.4%, 29.4% and 3.9%, respectively, whereas the individual mean PDCs for antihypertensive and antidiabetic medications did not improve after a CMR.5 A quasiexperimental study by Moczygemba et al. was conducted to determine the effect of pharmacist-conducted telephone MTM consultations on DTPs, medication adherence and total drug costs.6 The study included 120 Medicare Part D beneficiaries in Texas randomized in a 1:1 ratio to the intervention or control group between May 2007 and January 2008.6 Patients in the intervention group received a telephone CMR that identified DTPs and the need for preventative therapy, and were provided follow-up consultations on a case-by-case basis depending on the patient’s needs.6 One of the main outcomes of the study was change in medication adherence as measured by the average MPR for all of a patient’s medications from baseline to 12 months following delivery of the CMR.6 Results showed that the average MPR was similar in the intervention and control groups at baseline (0.53 ± 0.15 and 0.55 ± 0.18, respectively).6 Medication adherence did not improve significantly at the 12-month follow-up with average

MPRs for the intervention and control group of 0.51 ± 0.18 and 0.57 ± 0.17, respectively.6 Additionally, no significant predictors of improved medication adherence were identified by the multiple regression analysis.6 In a prospective, pilot study by Moore et al. investigators determined the impact of MTM services on adherence as measured by MPRs, along with other indicators of healthcare utilization.7 This nationwide study included 4,500 adult patients at high-risk for drug therapy problems (DTPs), which was defined as 14 or more claims within a 120-day period and/ or had claims that suggested an omission of recommended therapy or the presence of inappropriate therapy in the treatment of conditions such as, but not limited to, asthma, DM, heart failure (HF), or heart disease.7 The MTM service included an initial CMR conducted over the phone by a centrallylocated, specially-trained clinical pharmacist for a large pharmacy benefit manager company, as well as two follow-up consultations with the same clinical pharmacist that were completed within a year following initial enrollment in the program.7 The intervention group consisted of patients that were invited and agreed to participate, whereas the control group consisted of those declining to participate in


the MTM service.7 Pre-post MPRs for five chronic conditions (DM, HTN, dyslipidemia, depression and asthma) were measured to determine the difference in adherence rates between the intervention and control groups.7 The MPRs for HTN and dyslipidemia increased by 2.29% and 2.1%, respectively, from baseline in the intervention group, whereas the control group showed decreased MPRs of 2.31% and 2.61% for those conditions, respectively (both P < 0.001).7 The MPRs for DM, asthma and depression medications did not change from baseline in either group.7 A report prepared for CMS evaluated the impact of MTM in chronically ill Medicare beneficiaries that were enrolled in stand-alone PDPs or MA-PD plans.8 Patients that received a CMR were matched to a similarlysituated control population that did not receive the service.8 Medication adherence for targeted conditions, such as HF, DM and chronic obstructive pulmonary disease (COPD) was improved with the receipt of a CMR, whereas adherence to medications for non-targeted conditions improved to a lesser degree.8 Adherence to evidence-based therapy among patients receiving CMRs was estimated to be 15-35% higher for those with DM, 11-40% higher for

those with HF, and 11-26% higher for those with COPD, compared to the control group.8 Overall, the consensus of the report indicated that conducting MTM without a CMR was associated with increases in costs, whereas including a CMR resulted in decreased overall costs of care.8 The conclusion of this CMS report was that effective MTM requires the right patients be targeted with the right services in order to provide economical and humanistic benefit.8 A prospective, pre-post comparison study by Steele et al. was conducted to evaluate the impact of pharmacist-conducted, home-based CMRs on DTPs in geriatric patients.9 The study took place at three grocery store chain community pharmacies affiliated with three independent living facilities and included 25 geriatric patients that were using pharmacy delivery services for at least three chronic medications.9 Participating patients were given a medication action plan at the conclusion of the CMR and received a follow-up telephone call two weeks following the initial service.9 Investigators reviewed participants’ medication profiles for three months following the intervention to determine if DTPs had been resolved.⁹ The primary outcome measures were change in number of DTPs per patient and change in four of the ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

CMS triple-weighted star rating performance measures; medication adherence for RAS antagonists, medication adherence for oral antidiabetic agents, medication adherence for statins, and use of high-risk medications.9 Results from the study indicated that the average number of DTPs per patient decreased from 3.4 ± 2.06 to 1.48 ± 1.68 (p<0.05) in the three months following the CMR.9 The most common DTPs identified during the CMR were nonadherence and incorrect administration/technique, both of which were significantly reduced after the CMR (p=0.012 and p=0.010, respectively).9 Of note, only one star rating performance measure, medication adherence for HTN, significantly improved as a result of the intervention.⁹ Approximately 68% of patients were adherent to HTN medications at baseline and 91% were adherent in the three months following the CMR (p=0.016).9

A Meta-Analysis of MTM Services Impact on Medication Adherence

A meta-analysis was performed by Viswanathan et al. in an effort to summarize the effect of MTM interventions on medicationrelated problems and their downstream outcomes among outpatients with chronic diseases.10 All studies included in the 21

analysis were required to provide MTM services that included a comprehensive medication review, patient-directed education, care coordination and an opportunity for follow-up.10 Of note, the review was limited to ambulatory care settings and included evidence from randomized clinical trials, cohort studies and casecontrol studies.10 Many of the aforementioned trials above were included in the review. Analysis of the trials showed that MTM interventions improved medication adherence by approximately 4.6%; however, the percentage of patients achieving a threshold adherence level was not significantly improved in patients receiving MTM services (odds ratios [ORs] 0.99 to 5.98).10 Authors concluded that MTM interventions may reduce the frequency of some DTPs, including nonadherence; however, the available evidence is insufficient to support its role in overall improvement in health outcomes.10


Overall, evidence for the impact of CMR completion on medication adherence rates seems to be inconsistent and lacking. Effects on adherence seemed to vary depending on the method of CMR delivery, the training of the pharmacist performing the CMR,


the presence of follow-up, the disease states corresponding to the medications being measured and the manner in which the medication adherence was being measured. Studies by Moore et al. and Moczygemba et al. both utilized telephone-based CMRs in their intervention group; however, Moore et al. was able to demonstrate improvement in MPRs for HTN and dyslipidemia medications while Moczygemba et al. was unable to demonstrate improvement in average MPR for all medications.6,7 Whether or not the CMRs delivered in Moczygemba et al. improved individual MPRs for HTN and dyslipidemia medications cannot be determined from the analysis, yet the improvement seen in Moore et al. may be due to special training provided to the clinical pharmacist that focuses solely on MTM services, the multiple mandatory follow-up consults over the course of 12 months or the larger patient population that allowed investigators to see a difference between the intervention and control groups.6,7 The significant improvement in antihypertensive medication adherence with the use of home-based CMRs with mandatory telephone follow-up in Steele et al. suggests that patients in independent living facilities might benefit most from face-to-

face CMRs where pharmacists are able to develop rapport and educate patients about the asymptomatic nature of certain disease states.9 Other limitations of these studies include the time period in which they were completed, as well as the metric used for the measurement of adherence. Many of the earlier trials, such as Branham et al. and Moczygemba et al. were conducted before the development of the Medicare star ratings system. The drivers from health plans to affect these adherence rates and the focus on specific medication classes was not present at the time of these studies, and therefore, may demonstrate completely different outcomes if conducted in today’s healthcare environment. Additionally, both studies by Moczygemba et al. and Moore et al. utilized MPRs to measure adherence. The use of MPR rather than PDC may have overestimated adherence rates at both baseline and follow-up, thus not permitting investigators to see a difference in intervention groups that received a CMR.5-7 While measuring the impact of CMR completion on medication adherence provides evidence to health plans of pharmacists’ contributions to the improvement of their performance measures and overall star ratings, evidence


of higher quality care ultimately comes in the form of improved health outcomes. An increase in adherence has been shown to improve health outcomes and lower healthcare costs; therefore, studying whether CMR completion contributes directly to these measures may be more effective in demonstrating the worth of

pharmacists’ care rather than measuring the effect on adherence alone.11 Improved medication adherence as measured by PDC or MPR is only an estimate of adherence. These do not account for those patients that pick up their chronic disease medications and omit doses at home. The true impact of pharmacists’ care by

CMR completion will be shown by measuring health outcomes and overall costs of care in recipients of these MTM services and is an area of opportunity for further investigation to demonstrate the value of the pharmacist in new health care initiatives.

1. O’Sullivan J, Chaikind H, Tilson S, et al. Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. http://royce. house.gov/uploadedfiles/overview%20of%20medicare.pdf (accessed 2017 Feb 17). 2. American Pharmacists Association and Academy of Managed Care Pharmacy. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharm Assoc (2003). 2014;54(3):228-40. 3. Nau DP. Proportion of Days Covered (PDC) as a preferred method of measuring medication adherence. http://pqaalliance.org/resources/ adherence.asp (accessed 2017 Feb 19). 4. Zhao B, Wong EC, Palaniappan L, et al. Estimating patient adherence to medication with electronic health records data and pharmacy claims combined. http://support.sas.com/resources/papers/proceedings13/167-2013.pdf (accessed 2017 Feb 17). 5. Branham A, Moose J, and Ferrari S. Retrospective analysis of medication adherence and cost following medication therapy management. Inov Pharm. 2010;1(1):12. 6. Moczygemba LR, Barner JC, Gabrillo ER. Outcomes of a Medicare Part D telephone medication therapy management program. J Am Pharm Assoc (2003). 2012;52(6):e144-e152. 7. Moore JM, Shartle D, Faudskar L, et al. Impact of a Patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013;19(3):22836. 8. Perlroth D, Marrufo G, Montesinos A, et al. Medication therapy management in chronically ill populations: final report. Prepared for CMS by Acumen, LLC and Westat; 2013. 9. Steele, KM, Ruisinger JF, Bates J, et al. Home-based comprehensive medication reviews: pharmacist's impact on drug therapy problems in geriatric patients. Consult Pharm. 2016;31(10):598-605. 10. Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings: A systematic review and metaanalysis. JAMA Intern Med. 2015;175(1):76-87. 11. Esposito D, Bagchi AD, Verdier JM, et al. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care. 2009. 15(7):437-45.




Joint Annual Conference Sept. 7–10, 2017

Marriott St. Louis Grand

Meet Us in St. Lou is



The Location

HOTEL INFORMATION Book your hotel reservations now for the MPA & IPhA Joint Annual Conference September 7–10, 2017 at the Marriott St. Louis Grand Hotel located at 800 Washington Ave, St. Louis, MO 63101.

Conference Hotel Reservation Link https://aws.passkey.com/event/48985882/owner/84420/home For phone reservations, please use the following dedicated Group Reservations phone numbers to make sure you can access special block rates of $179/night + taxes and ensure you book within the block. Room block cut-off is August 15, 2017. Reservations Toll Free: 800-397-1282 Reservations Local Phone: 1-877-303-0104 Marriott St. Louis Grand Hotel may not be able to accept reservation inquiries on certain non-group reservation phone numbers. Please do not call the hotel's direct line. Use the numbers above to ensure you received our group rate of $179/night + taxes for the conference.



Connect with the experts to help keep your understanding at the cutting edge. Speak face-to-face with some of the leading minds in pharmacy, and ask them some of your most burning questions. You will have the opportunity to discuss thought-provoking articles with the authors themselves, and share your own unique experiences to help contribute to their studies. Take on new perspectives. Reading trade publications at your desk is essential for learning new things and keeping up-todate on industry developments. But sometimes, it takes a new environment, and a new perspective to truly transform your thinking. Getting out of your comfort zone and shaking up your routine can work wonders for getting out of ruts and revitalizing your business.

Reasons to attend conference

Stay at the head of the field, by connecting with experts and attending our annual Expo. There you can learn about all the newest tools, technologies, and practices that are helping to make our business better. If there’s one reason you should come to the 2017 MPA & IPhA Conference, it’s to help yourself become a better professional. 26

Re-energize your passion for the field by conversing with like-minded professionals and industry specialists. On-line learning programs and discussion boards can be helpful, but they lack the energy and enthusiasm that can only come from faceto-face interaction. Share your perspective, learn from others, and reinvigorate your enthusiasm for the field. Hone your skills by sharing insights with peers, and taking part in some of the many programs that will be offered: Emergency preparedness, Illinois Law Update to stay current on changes in regulations, and Naloxone Update encompassing perspectives from Missouri and Illinois.

Network with some of the region’s leading pharmaceutical professionals; or just catch up with some old friends. At the core of our convention is the idea of open dialogue and exchange. By sharing our insights, experiences, and ideas, we can all work together to make our industry even better.


The IPhA & MPA Foundations are excited to announce the following FUNDRAISERS to be held at this year’s joint annual conference: We are currently seeking donations for these events. If you would like to donate an item(s) for our silent auction or bottles of wine for our Wall of Wine, please send a brief description and value of your donation to Erica at ericab@ipha.org or Robyn at robyn@morx.com.

Silent “Pharm Auction”

Wall of Wine Trivia Night IPhA Foundation Mission Statement

MPA Foundation Mission Statement

The IPhA Foundation provides support in the form of grants, scholarships, and professional expertise for pharmacist delivered patient care initiatives designed to optimize patient health outcomes, student participation in IPhA activities, and the preservation and promotion of the history of pharmacy in Illinois.

The Missouri Pharmacy Foundation has been assisting committed pharmacy students with their scholarship program since 1951. With the foundation’s encouragement, pharmacy students are able to advance in their learning and knowledge, as well as share their love for the practice. Your contribution helps to fund these scholarships and the future of the pharmacy profession.

Contributions to the IPhA Foundation, a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code, are deductible for computing income and estate taxes. ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG




Saturday 9/9

5:30 - 7:30p

Registration Opens




Welcome Reception at St. Louis College of Pharmacy Campus

7:00 - 7:20a


7:20 - 8:20a


8:30 - 9:30a

Where Do You Fit? Piecing Together the Puzzle of Interdisciplinary Health Care Teams

8:30 - 9:30a

Illinois Law Update Missouri Law Update

Friday 9/8 7:00 - 7:20a


7:20 - 8:20a


7:00a - 3:30p

Exhibit Set Up

9:45 - 10:45a

Multiple Sclerosis Update

8:30 - 9:30a

Drug Pipeline and Industry Trends

9:45 - 10:45a

Digging for GOLD

8:30 - 9:30a

A Cascade of Updates: Hot Topics in Anticoagulation

9:45 - 10:45a

Social Media Use in Pharmacy

9:35 - 10:35a

USP 800: What You Need to Know

11:00a -12:30p General Session Suicide Prevention

Know Pain, Know Gain

12:30 - 2:50p

Lunch/Exhibits/Networking/ PharmAuction/Poster Presentations

10:45a - 12:00p General Session: Emergency Preparedness

1:45 - 2:45p

APhA ASP Chapter Networking

3:00 - 4:30p

Pharmacy Jeopardy X

12:00 - 1:30p

4:45 - 5:45p

Let's Check You Out: Obtaining Vital Signs in a Pharmacy

Drug Allergy: A "Rash"ionale for Treatment

Missouri Awards Lunch Illinois Awards Lunch

1:45 - 4:00p

Needle Facts: Immunization Update Part I & II

4:45 - 6:00p

Illinois House of Delegates

6:30 - 7:00p


1:45 - 2:45p

Still Feelin' the Burn? You May Have a Urinary Tract Infection

7:00 - 10:00p

President's Gala

Pharmacy Value Based Performance (In relationship to DIR) 3:00 - 4:00p

Keys to Successful Precepting in the Community Setting

Sunday 9/10 Time


All day

APhA's The Pharmacist & Patient-Centered Diabetes Care (separate registration)

8:00 - 9:00a

Joint Political Action Committee Breakfast

9:15 - 10:45a

Naloxone Update An Illinois & Missouri Perspective

LTC Mega Rule


3:00 - 6:00p

Student Business Plan Competition

3:00 - 6:00p

Patient Counseling Competition

4:10 - 5:15p

Keeping Up-to-Date, With So Little Time: Newly Approved Medication Review

4:10 - 5:15p

IL House of Delegates Roundtables

4:30 - 6:30p

Exhibits, PharmAuction and Networking


Alumni Receptions


MPA/IPhA Foundation Trivia Night Fundraiser (Doors Open @ 7:30)

11:00a - 12:00p CPESN Meeting THE




14 MissouriPHARMACIST July | Sept. 2017 Volume 91, Issue III


THE GATEWAY TO THE FUTURE OF PHARMACY CONFERENCE & TRADESHOW SEPTEMBER 7-10 | MARRIOTT ST. LOUIS GRAND | ST. LOUIS Name: ________________________________________________________

Credentials: _________________________________________________

Preferred Name for Name Badge: ________________________________

Spouse/Guest(s) Name (if attending): ___________________________

Company Name: _______________________________________________

Address: ____________________________________________________

City: _________________________________________________________

State, Zip: ___________________________________________________

Email: ________________________________________________________

Phone_________________________________DOB: _________________

NABP Number: ________________________________________________


PRICING OPTIONS Full Registration: admission to all convention functions (except pre-convention trainings), breakfast, lunch, one (1) Gala ticket, one (1) Exhibit Hall admission and lunch ticket. *Please note, the Gala tickets are not included in student pricing. They are available for an additional fee. Student sponsorships are also available to assist with coverage for those students who want to attend the Gala. Single Day Registration: Breakfast, lunch and entrance to exhibits. Gala tickets are not included in Saturday registration; can be purchased additionally.


Early Full Reg. Before 7/31

Early Single Day Thru 7/31

Full Reg. 8/1–9/4

Single Day 8/1–9/4

On Site Full Reg. 9/5–9/10

On Site Single Day Reg. 9/5–9/10


r $385

r $435

r $245

r $295

r $460

r $325


r $265

r $315

r $160

r $210

r $335

r $235


r $265

r $315

r $160

r $210

r $340

r $235


r $50 thru 9/4

r $50 thru 9/4

r $45

r $45

r $65

r $60


r $215

r $265

r $135

r $185

r $290

r $210

Before 7/31

Full Reg. 8/1–9/4

Early Single Day Thru 7/31

Single Day 8/1–9/4

On Site Full Reg. 9/5–9/10

On Site Single Day Reg. 9/5–9/10


r $585

r $635

r $445

r $495

r $660

r $525


r $465

r $515

r $360

r $410

r $535

r $435


r $301

r $351

r $196

r $246

r $376

r $271


r $65 thru 9/4

r $65 thru 9/4

r $60

r $60

r $80

r $75


r $215

r $265

r $135

r $185

r $290

r $210

r Saturday

r Sunday*


Online Registration available MoRx.com/Registration

ADD ONS * Child rates are for 16 and under.

r Adult $95, *Child $30 Additional Gala Tickets r Adult $25, *Child $15 Trade Show Luncheon r $50 Event Binder (complete with printouts of all conference materials


SINGLE DAY REGISTRATION I will be attending on: r Friday

GALA TABLE SPONSOR FOR 10 STUDENTS r $750 Student Table for 10 SPONSORED TABLE Tickets will be provided to purchaser to distribute. I want to encourage and support student attendance at the conference. I will gladly provide the following support

r $500 Summa Cum Laude r $250 Magna Cum Laude r $100 Cum Laude r Dean's List, Donation Amount: $


*There is no additional charge for Sunday's half-day sessions. r I will be attending the Opening Reception on

Please let us know if you have special, physical or dietary needs.

CANCELLATION POLICY We understand that circumstances arise that require you to cancel or send a

Thursday, September 7, 6-9p.m.

substitute. Refunds are granted in full up to 60 days and half up to 60 days and

TOTAL: $ ________________

half up to 30 days prior to the event. After that, no refunds will be issued, unless extenuating circumstances arise. Please notify the MPA of any changes prior to

PAYMENT INFORMATION to the Missouri Pharmacy Association is enclosed. r Check MPA's Tax Identification number is 44-0357135

the event to help facilitate the check-in process.

Credit Card:

You are responsible for making your own hotel reservations at the following:

r AmEx

r Visa

r MC

r DC


Name on Card: ________________________________________________

Marriott St. Louis Grand | 800 Washington Ave | St. Louis, MO 63101

Billing Address: ________________________________________________

Room rates begin at $179 plus tax per night. Call 800.397.1282 and ask for the

City, State, Zip: ________________________________________________

Missouri Pharmacy Association room block for reservations by August 15, 2017.

Card No.: ________________________ CVV: _______ Exp. Date: ______

MAIL TO MISSOURI PHARMACY ASSOCIATION 211 East Capitol Avenue, Jefferson City, MO 65101 Phone: 573.636.7522 Fax: 573.636.7485


16 MissouriPHARMACIST July | Sept. 2017 Volume 91, Issue III


Signature: _________________________________________Date: ______


We Need Your Help!

Why donate to our Silent Auction?

Contributions to the IPhA Foundation support the activity of the Association, advance the practice of pharmacy in Illinois, and preserve the history of pharmacy. Contributions to the MPA Foundation help to further the welfare, knowledge and integrity of the profession of pharmacy, and for the advancement of public health and welfare. Contributions to the IPhA Foundation and MPA Foundation, tax-exempt organizations under Section 501(c)(3) of the Internal Revenue Code, are deductible for computing income and estate taxes. Your name will be advertised as a donor in conference program materials and the 4th Quarter IPhA & MPA Journals.

Mail your items to:

Illinois Pharmacists Association 204 West Cook Street Springfield, IL 62704


ericab@ipha.org with the item(s) description and estimated value.

Questions? Contact Erica Burris at (217) 522-7300 or ericab@ipha.org. 30


This year, the IPhA & MPA Foundation Fundraiser will be a Trivia Night along with a Wall of Wine during the Annual Conference at the Marriot St. Louis Grand from September 7th – 10th.



Pharmacy Crime

A look at pharmacy burglary and robbery in the United States and the strategies and tactics needed to manage the problem. The following article is an excerpt from the 2015 Pharmacists Mutual Crime Report: https://www.phmic.com/wp-content/uploads/2016/07/PMC_CrimeReport.pdf

A National Wake-up Call and Response The theft of prescription narcotics from pharmacies is a problem that has grown over the past thirty years, gaining national attention in 2010 with the declaration by the Centers for Disease Control (CDC) that the prescription drug abuse had reached epidemic proportions. Driven by a change in how health care was delivered, the trend shifted from a focus on treatment to one of prescriptions. With the advent of the new millennium, we saw changing attitudes about the use of narcotic medications and an aggressive promotion by the pharmaceutical industry. Within that first decade, the number of people abusing prescription drugs jumped from The National Probability 3.8 million to 7 of any one pharmacy being million from 2000 to victimized by a pharmacy 2010. Diversion of narcotics to feed the crime (burglary, robbery, national addiction or employee diversion) was occurring at every step of the process, from drug design, to manufacturer and how the end user obtained and used the narcotics. On the front lines of the problem were the pharmacies who felt the ramifications in break-ins, armed robberies, diversion by employees, and administrative costs required to deal with ensuing regulatory requirements.


Since the CDC branded prescription drug abuse as an epidemic in 2010, extensive measures have been taken across the country to attack the supply side of the equation by making it harder for drug seekers to obtain narcotics. These measures include prescription drug monitoring programs, tracking prescription dispensing and ordering patterns, education and changes in how narcotics are


prescribed. While these measures are gaining ground, the number of addicts and the demand for drugs has not corresponded to increased limitations on supply. In some parts of the country, heroin use has replaced prescription drugs. In most of the country however, those looking for prescription narcotics continue to turn to pharmacies. Rather than legitimate prescriptions, the need is often filled by taking the drugs forcefully by breaking in when the store is closed, by threat of physical harm to employees and customers when the store is open, or through employee diversion. Unfortunately, suspicious circumstances surrounding burglaries are often tied to employee involvement. Costs to the pharmacy can be significant. Nationally, costs associated with burglaries and robberies are in the tens of millions annually. Beyond what the pharmacy pays in deductibles and potentially higher premiums, pharmacies must often invest thousands in improved security. Reports to the Drug Enforcement Agency (DEA), Board of Pharmacy, Insurance Company, police, suppliers and others can be extremely time consuming, and if the crime is serious enough to cause the store to be closed, the pharmacy can also experience cash flow interruptions. In some cases, the most significant costs are the intangible feelings of vulnerability and fear that accompanies armed robberies.


Detailed Pharmacist Mutual Crime Statistics

Number of Robberies Reported to the DEA









Our most reliable source of information on national pharmacy crime experience is the DEA simply because the information is based on mandatory reporting requirements. Over the past four years, pharmacy robberies have been trending up. Based on results reported by the DEA in July 2015, the increase is expected to continue. What makes this increase even more alarming is that not all robberies are reported to the DEA. Many pharmacies will not report attempts, break-ins without loss of narcotics, minor burglaries or even robberies when the dollar loss in minimal.



*Projected as of 7/1/15

The DEA indicates that about 36% of pharmacy crimes are the result of robberies. Pharmacists Mutual member company experience hovers at about 9% annually. One of the key reasons for the difference appears to be related to the experience in chain stores, where armed robberies are consistently a significant problem. This has prompted chain stores to implement time delay safes, tracking devices and armed guards to control the problem. DEA reports indicate that a relatively high percentage of pharmaceutical thefts involve pharmacy employees. Based on anecdotal evidence from crime reports, interviews with pharmacists, and reviews of video surveillance, much of this diversion occurs by providing intelligence to thieves about security systems, alarm codes, store layout and the location of target drugs. Data tells us about how criminals typically strike and measures that can be employed to limit the likelihood or extent of the theft. Overwhelmingly, the preferred method for gaining entry into a pharmacy is through the front door or window. Strong locks and reinforced glass are a logical investment. We also know that the single most important protective feature a pharmacy can use is a welldesigned and maintained alarm system. Local patterns of criminal behavior dictate the level of protection required.

Percentage of Pharmacy Crimes by Crime and Store Type Employee Theft


6% Burglaries

6% Robberies


66% 36% 31% Retail/Independent

Prevention is essentially impossible without a plan for apprehension and gettng the criminals off the street. These kinds of initiatives have been effective in areas like Indianapolis through pharmacy and police collaborative efforts as outlined in Ken Fagerman’s Staring Down the Barrel. Technology solutions are starting to emerge and show success in various parts of the country. These technologies include tracking devices and dye marking technology. Loss costs are generally concentrated in and around major metropolitan areas, but some of the largest claims experienced by Pharmacists Mutual member companies happened in towns of less than 10,000 population and rural areas.

Source: Drug Enforcement Agency



Protective Features

Protect the perimeter

All things being equal, a criminal is more likely to avoid a “hardened target” if they can. The more barriers that would slow them down or increase their chances of being caught, the worse it is. Obvious video surveillance, alarms, good lighting, alert employees, high counter tops, and an unobstructed view into the pharmacy from the outside tell the criminal that the theft is going to take some work. How do they know about the protective features? Because they visit the stores before they strike, or someone working in the pharmacy has told them. Video surveillance may help deter a crime, can be very helpful in alerting police to suspicious persons, and helps identify criminals when they do strike. Alarms are critical, possibly the most important protective feature a pharmacy can provide to limit the extent of any burglary attempt.

Install good, burglary resistant locks. Burglary resistant locks protect against the most frequently used tool to defeat door locks — brute force (hammer, vice grips etc.).

Get a good alarm and use it correctly Operating a pharmacy these days without a way to at least alert the criminals that someone knows they are there is like playing Russian Roulette with an automatic pistol. If they burglarize the pharmacy, they are free to take their time. With enough time, even the best safe can be breached. Where there are no alarms we have seen thefts of computers and other electronics, ALL narcotics, other high value drugs, and retail merchandise. Property damage can be significant.

Minimize what they can take in two minutes and maximize the threat of arrest. Break-ins and robberies, even attempts, will result in property damage or emotional trauma and in some cases physical injury. Ideally, protective systems will minimize the impact and deter future attempts.

The hardened pharmacy The idea of hardening the pharmacy is simply doing things that make the pharmacy less attractive to the potential criminal. The concept is to cause enough questions in their mind about their chances of success that they move on to another target. What kinds of things may discourage the criminal?

Lock target drugs up

The Hardened Pharmacy C




Many pharmacies still keep C2 narcotics in particle board or press board cabinets. Crooks know where to look for these, and can open one in seconds. The standing record is 32 seconds to smash the glass, hop the counter and pry the security cabinet open for a net of $25,000 in drugs. The best option is a burglary resistant safe that is visible from the front of the store. Security cabinets reinforced with steel and sturdy locks or gun safes that are bolted to the floor are other alternatives.



Video Alarm



Safe Glass Protection ILLINOIS PHARMACISTS ASSOCIATION • VOL. 80 - NO. 2 (2nd QTR 2017)

What Can Pharmacists Do To Protect Themselves? Protection against someone entering the store with a weapon or indicating they have a weapon is a problem because, short of locking down the pharmacy, it is almost impossible to stop criminals from walking in off the street. Measures that can and have been employed:

1 Security experts strongly recommend that a pharmacy plans for

a robbery event. Discuss roles and behaviors when and after a robbery occurs.

2 Train the staff on what to do when a robbery occurs. Training videos are available at no charge from RxPATROL, www.rxpatrol.org, and local police are often willing to provide education on what should be done.

3 Panic buttons at fixed locations or carried by pharmacists provide an opportunity to notify the police without trying to place a call. If panic buttons are considered, make sure you know how the police will respond.

4 Opening doors with a buzzer and letting people in individually may help, but is not totally effective. People follow others in, some will hold the door open, and it is impossible for the pharmacist to identify every potential robber. Robbers come in all shapes and sizes, ethnicity, sex and economic background. This technique can be effective in enforcing posted requirements that persons entering the store remove hats, glasses and hoodies before entering. If you do use the buzzer, make sure the pharmacist has a clear view to the door.

5 Deploy tracking devices. Tracking devices, disguised to look, feel and sound like narcotic bottles, provide alerts to a monitoring service, which notifies the police to the location of the thief. Boasting a 70% apprehension rate, these devices provide perhaps the best defense against armed robbers by getting them off the street.

6 Time delay safes. There is anecdotal evidence that the use of time delay safes is having an impact in reducing pharmacy robberies. Robbers, interested in a quick score, do not generally have an interest in standing around until the locking mechanism allows the safe to be opened. If most target drugs (narcotics) are in the safe, the robber has to weigh the risk of getting caught against the expected return. If they don’t feel there are enough drugs to justify the risk, they will move on to another location.

7 Armed pharmacists. Pharmacists Mutual’s position on this is that the decision to carry a firearm is up to the pharmacist. While firearms have been successfully used to protect against armed robbers, there are some key concerns that need to be considered before deciding to arm oneself.

Method of Entry Front Door/Window Rear Door/Window Side Door/Window Robbery Wall Roof Drove Into

51% 13% 10% 10% 10% 5% 1%

While we have seen success in controlling pharmacy crime, there is a long way to go. These crimes still cost Pharmacists Mutual and members millions of dollars each year. Pharmacy burglaries and robberies represent 12% of pharmacy segment premiums for the past five years and average over $3.7 million annually in loss costs. In addition, a driving force behind the need for continual focus is the interest our member companies desire in seeking answers to the threats from break-ins and armed robberies.




Phi Lamba Sigma Founded at RFU

osalind Franklin University of Medicine of Science (RFU) College of Pharmacy (COP) founded the Epsilon Gamma Chapter of the Phi Lamda Sigma (PLS) Pharmacy Leadership Society. Twenty students with a commitment to pharmacy and a record of leadership at the College, University and external community level were inducted to PLS by Mary Euler, PharmD, Executive Director of PLS, during an April 21st on-campus ceremony. The Society’s mission to support pharmacy leadership through the recognition and fostering of pharmacy leaders aligns with the mission, vision and strategic goals of RFU and the COP. Members were selected via a process that included a letter of support from a faculty member. The Chapter will consider membership annually for a limited number of new members.

Inaugural membership selection proved challenging given the number of highly qualified applicants. “It’s a good problem to have,” said Jessica Cottreau, PharmD, Epsilon Gamma Chapter advisor, Chair of Pharmacy Practice, and one of six faculty who are PLS alumni. “We have many involved and dedicated students who I know will have an incredibly bright future. PLS membership, however, is a way to recognize and mentor those who are not only passionate, dedicated and serviceoriented, but those who have already begun to emerge as the true leaders of tomorrow.” The Epsilon Gamma Chapter selected Janeen Winnike, RPh, Assistant Dean for Student Affairs, and alumnus Jayzle Boyd, PharmD, ’16, for the honors of PLS Faculty Member and Honorary Member, respectively. Congratulations to all newly inducted PLS members throughout Illinois.

what’s the

difference? Transformation. We’re changing the way you look at Long Term Care. We’re a team of dedicated LTC Professionals with over 75 years of combined experience that can provide turnkey ideas for starting, operating and growing your own LTC Pharmacy. With the One JM Smith Model, we’re able to provide a portfolio of hardware and software solutions to have you up, running and profitable. Smith Drug Company. Differentiators.



1.800.572.1216 ext. 1230 smithdrug.com

SUPPORTING PHARMACISTS. ADVANCING CAREERS. Find the best jobs and highly qualified pharmacists Illinois has to offer.




What’s With YOU?” The 2017 2nd Quarter Edition of Illinois Pharmacist will begin a new “What’s New With You” section of our publication. In “What’s New With You”, we intend to highlight exciting life events that are happening with our members. This could include: Marriages, New Births, Anniversaries, Award Winners, New Job Positions, Sympathies, or anything related.

Please submit any exiting news you would like to share with the Association to Sandra Dial at sandrad@ipha.org. We would love to include a photo with your announcement!


Words From

Our Wise …

We have an endless supply of knowledge within our Association and we need to hear from YOU!

We are looking for a few of our most cherished members, who have so much to give and to learn from, who are willing to take the time to write an article once or twice a year to be published in our Journal each quarter. Our hope is that we have more than one willing to write and therefore burden on none. We need to hear from you, learn from your experiences. Articles need be of topics related to the world of Pharmacy. Be it, business, customer service advise, lessons learned. • What was your toughest lesson in business? • How did you deal with demanding customers, customer service, financial planning, or financial budgeting? • Differences between then and now. How is pharmacy changed since you first began? • What do you feel pharmacy needs today? • What do you wish someone would have told you sooner? These are just a few ideas, you have many stories and experiences to flood our page.

We look forward to hearing from you! Please submit your article to Sandra @ sandrad@ipha.org or you may call her at the office 217-522-7300 if you have questions.



A Buying group for independent retAil phArmAcies

...owned by 19 state pharmacy organizations ...a leader negotiating on behalf of independents ...saving pharmacies money for more than 25 years ...financially supports the state pharmacy organizations ...serving pharmacies nationwide 1-888-200-0998 | www.pacealliance.com

Midwestern University

Congratulations to the Midwestern University 2017 Graduates Fahma Adan Abdirahman Feda Abu-Mallouh Roud Hicham Al-Nabulsi Karam Alkakoz Nupur Amin Zarha Amlani Peter Andrawis Nashwan Gary Ankawi Uzma Arif Aaliya Sultana Aslam Randall Vincent Ayar Ameera Nahhas Azmeh Farron Shaheel Baksh Asif Irfan Bhagat Uzma Jamil Bhatti Bridget Nicole Biskup Adam Gregory Brzeszkiewicz Elizabeth Marie Buchanan Tuan Quang Bui Caitlin Joy Bulthuis Chelsea Nicole Burns Chao Cai Han Cai Jeanine Elizabeth Campa Julie Anne Cataldo Lejla Catovic Orgesa Cepo Tina Chen Yu Ting Chiu Hankyung Cho Li-Wun Chu Tyler James Clemons 40

Kayla Joyce Cook Brooke Ashley Culen Elizabeth Ann Davidson John Day Sharn K. Deol Daniel Tu Dinh Lisa Do Matthew Fenton Doolin Jacob Daniel Durham Adebola Erogbogbo Tatheer Fatima Mohammed I. Fawaz Zahi Ramzi Fawaz Jacob Ryan Fischer Angie Galetti Ana Maria Gallardo Joshua Rebano Gener Haneen Rasheed Ghanayem Alex Hadesman Christian Thomas Hagan Gregory Arthur Hakala Sonya Hami Saba Nagi Hamid Shetha Othman Hamoud Eileen Hang Holly Joy Hansen Holly Ann Harrison Fahima Muse Hassan Joseph Hegazin James Richard Hillman Amy Hoang Kaitlin Anne Hoepfner

Dustin Brian Hoppes George Nick Hotousiotis Ina I. Ilieva Georgiana Ismail Shermie Shojan Jacob Rebecca Jett Kenya Bianca Johnson Shobin Chummar Joseph Niree Kalfayan Christopher William Kapolas Georgia Katsoulis Dalbir Kaur William Kelly Bianca Duraid Kilano ChungYun Kim Hyunju Kim Risa Kim Sean M. Kita Nathalie Mike Kizy Stacy Danielle Kmentt Patrick J. Korienek Jan Di Kum Alyssa Lahm Irfana Yakub Lakada Anh Long Lam Thuy Thanh Lam Lucas Parr Landsmann Kevin M Lawlor Christine Le Jane Young Mee Lee Jennifer Lee Margaret Lee


Tina Lertharakul Edith Liang Alexander Eison Lo Hwai Man Luu Camelia Maali Danielle Rae Mangen Kazvin Firdos Marfatia Serjo Martinez Dalila Masic Inela Masic Kiara Simone Mason Mehwash Masood Reham Ahmed Mohamed Sara Mossa-Basha Tracie Lynne Motyka Lauren Ashley Musa Greta Musaraj Asmaa Ibrahim Mustafa Paul J. Myles Tuba Nahid Rhobinson Nato Kristen Michele Nelson Daniel Ngo Thomas Tho Ngo Harrison Duc Nguyen Lan Thanh Nguyen Lisa Marie Dan Thuy Nguyen Peter Hoang Nguyen Rosie Nguyen Thien-Kim Van Nguyen Thuy-Tien Ho Nguyen Vi Thuy Nguyen Vinnie Quan Nguyen Damon Eugene Olson Jose Luis Ortiz Jr. Kavita A. Parikh Han Jin Park Elisabeth A. Pasquini

Krystian Paszek Kavin Patel Megha B Patel Nileshkumar C. Patel Parth Mahesh Patel Priya Kamlesh Patel Vaidehi Virendra Patel Derek Kyu-Hock Paw Jessica M. Peng Danielle Joy Petric Danielle Si Pham John Joseph Prestianni Adrianna Anh Lan Quan Benjamin N. Quaye Sabrina Salah Rizk Diamond Ni'rel Roby Fernando Luis Rodriguez Anne Madelaine Obenza Roxas Momcilo Ryan Jineen Sadi Nishan Paul Sakadjian Husam Saleh Lauren Gale San Juan Elizabeth Schuhler Michael William Serlin Rithisak Seth Adit Dilip Shah Jhanvi Bharat Shah Jill Dipak Shah Mit Shah Suleman Shah Aishwarya Shankar Sanya Mariam Siddiqui Veronika Slomiany Nadia Stariha Merika Ariel Tuvell Starr Matthew Kyle Steinbrenner Jaclyn Elizabeth Sullivan ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

Kia A. Sutton Alison Rachel Svoboda Wajiha Fatima Syed Christopher Allen Tabamo Regina Takamura Samantha Toliusis Jessica Toma Michelle Susan Tomeczkowicz Maram Yasser Toumah Andrew Pham Tran Chau Tran Linh Tuyet Tran Pauline Tran Ryan Michael Trieglaff Rebecca Ann Twaroski Chandni Shailesh Vaidya Seriphone Vang Sara Michelle Vihnanek Nathan Edward Vomhof Ivan Vukovic Kaitlyn White Mariana Xhemo Anna Xie Shi Ra Youn Deanna Zadorozny Kate Reena D. Zamora


Congratulations to the 2017 graduates from the University of Illinois at Chicago College of Pharmacy Chicago & Rockford Campuses Christopher A. Adams Adeola Toheebat Adediran Nimah Ahmed Patcharavi Akramunkongvanich Omar Abdulaziz Al Shaya Tanja Alavanja Atheer Othman Aldairem Mehmet Osman Alegoz Quratulain Ali Rana Ibrahim Aljadeed Raniah Ibrahim Aljadeed Bashayer Sultan Alshehri Kyle Edward Andrews Emily M. Armgardt Raya Atshan Mateusz S. Baczek Karen Bae Jacqueline R. Baker Zachary Reed Bannor Brandon Barringer Eldred Mohammed Bell Lillian Ting-Ting Maria Bellfi Coreliss Blue Jovan Borjan Matthew Borris Mitchell James Broderick Jordan L. Burkholder Andrew Campos Katrina Aco Capapas Michael Carey Stephanie Megan Chang Wendy Chen Yafang Cheng Bhargavee Shah Chhabra Anthony Chi Chuan Chiang Min Choe 42

Sarah Beth Chismark Yeeun Chung Stefanie M. Cisek Lirije Culafovski Lauren Marie Cunico Riya D'Silva Joseph Q. Dang Patrice H. Davis Crystal Dedes Matthew F. Deraedt Riya M. D'Silva Shelby Paige Duncan Elizabeth Ann Eitzen Mariet Eivazi Haytham Mahmoud Eleissawy Lauren Ashley Endriukaitis Sandy Alaa Ezzet Ayotunde Fajembola Kristina Ann Falk Angelico Flores Fernandez Sviatlana Borisovna Ferri Mark J. Florzak Katarzyna Anna Fortuna-Garcia Robin Renee Frank Rachael Freeman Ariane Aguilar Ganza Daniel Gratie Leena Hamadeh Maria Magdalena Hernandez Brittany C. Hickey Niveen Moayed Hilal Matthew Caleb Holderly Matthew Horney Kevin C. Hoshizaki An-Li Hsu Grace M. Hsueh

Quoc Anh Huynh Dawn J. Hyatt Sabrin B. Jaber Jacob Johnson Charles Jonathas Iyoung Michelle Jung Emily Megan Kalusetsky Weiliang Kang Michelle R. Kapugi Kelly R. Kawabata Betty Michaela Khilevich Ashley G. Kim Bryan Kim Joolia Yejin Kim Bikgwen Selena Ko Nima Kohanpour Jung Ju Kohm Marina N. Koval Rebecca Katherine Kozuck Meghan Kross Jenna A. Kunz Johan Laker Ana Lazarevski Nha Le Benjamin Y. Lee Brittany Anne Lee Michelle M. Lee Jamie M. Leone Peter J. Leszczewicz Ina Liko Po-Hung Lin Ridge Lin Kinga Lis Xuxuan Liu Laurina Luo Brittany Lynn Manzoline


Albert Xu Mei Diana Y. Mei Jason Mei Nataliya Milikhiker Aimee J. Miller Randie Rae Molina Jeremy J. Mozwecz Jeffrey Neal David A. Nelson Kourtney A. Newell Phuc Thi Nguyen Kari Elizabeth Nishikawa Diana N. Nowicki Sandra Odicho Babatunde Isaac Ogunbiyi Kara A. Oherron Jordan S. Ordonez Kristin Mary Orr Farah Osman Abena Kufour Owusu-Ansah Stacey Jane Pan Gennaro A. Paolella Little Irene Grace Park Marissa A. Pasquini Alisha V. Patel Bhumi Dinesh Patel Parth Arvindbhai Patel Prital Hiteshbhai Patel Rina N. Patel Ruchik S. Patel Yesha Yogesh Patel

Andrew Pepin Connor Michael Perkins Patricia Magdalena Pernal Paulius M. Petrosius Elizabeth Thuong Pham Christopher P. Phillips Elmor D. Pineda Davis Mario Pohly Ana Popovich Leo S. Pratt Maen Qatoum Jamie Elizabeth Rayahin Hauraa Hassan Raychouni Lance C. Rodriguez Yamili Rodriguez Nabiha F. Sabiri Aisha Saeed Salma Muhammad Salah Iman Salim Shivani S. Salvi Ashley Rose Santore Julia Sapozhnikov Eric Sean Saucedo Hans Richard Scheerenberger Jamie Marie Seiffert Joshua G. Sellers ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

Katherine Sencion Mohammed Siddiqui Angeline Tracy Souvannasing Jelena Stanojevic Timothy Edward Stoehr Nila Edonna Sturlin Rafia N. Syeda Paulina E. Szczepaniak Diane Aurore Takouam Hardik M. Thakkar Jelena Toro William Trinh David M. Umali Joshua Uvodich Liya A. Vazhappilly Juan Manuel Villa Nevin Paul Walker Anmin A. Wang Kali M. Weber Adorable Angela Weng Amber Williams Rene A. Williams Connie Yan Jewel S. Younge Bryan D. Zarek Connie Zhou 43

Chicago State University College of Pharmacy

Chicago State University College of Pharmacy Congratulations to the Graduating Class of 2017 Mesay Abebe

Jennifer Kendrek

Arpita Patel

DeAndrea Abney

Wassim Khanafer

Meera Patel

Emmanuel Abodoh

Marcella Kinaya

Mary Pfister

Mohamad Aboukhodr

Bernice Koo

Treasure Pough

Hea Re An

Nancy Koo

Jessica Reyes

Harsukhjeet Atwal

Greta Kravetskiy

Devin Ross

Se Hee Cho

Nicole Latimore

Mey Saeteurn

Hyun Choi

Hanifath Lawani

Sung Seo

Octavia Dunn

Jei Lee

Alli Shafran

Festus Durugo

Jennifer Lim

Timothy Shields

Amanda Firmansyah

Traiana Mangum

Alicia Simale

Hao Wen Fu

Gia McKnight

Gurjit Singh

Anolan Garcia Hernandez

Ruel Mendoza

Folarin Smith

Manuel Gomez

Fadumo Mire

Kaitlin Stanislawski

Ruchita Goyani

Amyra Muhammad

Janelle Sulaiman

Gregory Grooms

Halina Myrda

Crystal Tayah

Medhin Haile

Vrinda Naik

David Tio

Amanda Hernandez

Motaz Nassan

Lyly Tran

Brittany Huff

Ana Nevarez

Kathy Twardus

Samih Husseini

Hanh Nguyen

Linda Volland

Patrick Janes

Hieu Nguyen

Danny Wolak

Michelle Jara

Olamide Olayemi

Jason Wu

Andrew Jeon

Olalekan Oguntoba

Tomasz Jurga

Ivie Oriakhi

Joanna Kaczmarczyk

Lance Parsley



Graduates TO THE 2017

IPhA is very proud of your accomplishment!



We would like to salute ALL OUR 2017 GRADUATES Nathan Abell

Bethany Chew

Barbara Goodwin

Kaitlyn LaBoube

Stephanie Adams

Michelle Chicoineau

Jacqueline Gosney

Salvatore LaFerla

Deanna Alexander

Susan Cho

Michael Gould

Kevin Lee

Hajar Alqahtani

Mahima Chojar

Eric Goulden

James Lidy

Sanaa Alsulami

Ronak Chokshi

Nicole Gramlich

Ai-Chieh Lin

Brandon Andereck

Heather Cohen

Danielle Gray

Alana Little

Greg Anderson

Kelly Costello

Amanuel Habtu

Lauren Little

Victoria Anderson

Nick Cowley

Rim Hadgu

Anthony Loepker

Bincy Augustine

Kamara Cox

Philip Han

Christopher Lofky

Elianna Axelbaum

Marissa Cruse

Clint Harkrader, Jr.

Cody Lohmann

Shefali Barot

Lemil Dabney

Andre Harvey

Emily Love

Hannah Baublitz

Anne Dall

Daniel Hemann

Lawrence Martin

Cally Beckemeyer

Courtney Darrah

Mark Hofelich

Kristina Mazdra

Jessica Berger

Alex Davis

Mara Hofherr

Matthew McKenzie

Benjamin Bibliowicz

Antoinette Davis

Elizabeth Holtman

Jessica Merlo

Andrew Biekert

Julie Davis

Molly Hood

Shelby Meyers

Kelsey Birkner

Amy Diekemper

Megan Horvath

Samuel Mikovich

Alexandra Bixby

Ivan Dobrichkov

Katelyn Hosselton

Benjamin Minch

Sean Blackledge

Kyle Dreier

John Hunter

Caitlin Minnick

Georgiana Boeckmann

Lindsay Dreier

Sameera Hussaini

Megan Mitchell

Brian Bohn

Christina Dunivan

Jessie Nia Hwang

Nathan Moehring

Melissa Bolliger

Nicolette Duong

Daniel Jaderko

Zoya Mohammed

Lisa Boone

Clayton Earhart

Stephanie Jaderko

Brianne Moore

Daniel Britt

Kaitlyn Edwards

Jordan James

Brittany Mueller

Shelby Brown

Amanda Empson

Ji Hae Jang

Mikayla Muzzey

Samantha Bryant

Morgan Epps

Young (Jiwon) Jang

Brittney Naumann

Leah Buhr

Moriah Fakes

Morgan Jones

Bushra Naz

Kathryn Bui

Alexandria Falck

Aimee Jose

Lana Nguyen

Amanda Bultas

Eric Farthing

Katy Kehl

Mai-Uyen Nguyen

Joseph Buse

Alexa Faulkner

Anne Kennedy

Nhu Ai Nguyen

Emily Carroll

Jason Ferrer

Carly Kersten

Samantha Nguyen

Christian Ceretto

Rachel Franz

Doyoung Kim

Talis Nguyen-Brics

Madison Chapman

Cheerlyn Fredrick

Hye Kim

Julie Nickelson

Xue Chen

Rebekah Friesz

Nicholas Kovarik

Charles Oakley



Oluwatoyosi Olayinka Jenna Olson Corrie Opolka Steven Ortiz Ronnie Page Eric Pan Brian Pankey Jinho Park Jeffrey Pasucal Megha Patel Sagar Patel Aubrie Patkus Stephanie Pavlov Drew Pentland Steven Phan Katherine Phillips Trent Podnar Nicholas Potter Avvari Prasad Nancy Quan Joseph Raible Angela Ramey Sabeena Raza Amanda Recchione Mariam Rehman Ashley Roberts Kathryn Robinson Alisha Romanotto Ashley Rose David Ross Dalton Rowden

Brad Rumancik

Elaine Tucker

Sakina Saaduddin

Gozie Uzendu

Rachel Saltzman

Thomas Valiaparampil

Sarah Samuel

Dana Vance

Nicole Schmidt

Nicholas Vierling

Samantha Schulte

Jennifer Voong

Courtney Scimio

Neil Vora

Jason Scott

Meredith Voss

Laura Seier

James Wade

Matthew Siambanes

Emily Wampler

Carmen Stach

Joshua Wampler

Blake Stigall

Xi Wang

Amy Suh

Clinton Washington

Erik Suh

Samantha Watson

Brittany Taake

Trey Weishaar

Stephanie Thottathil

Ashley Werle

Katelyn Toeniskoetter

Rebecca Willey

Kelsey Toler

Abigail Williams

Kayla Tompkins

Nichole Willoughby

Katy Toothaker

Jessica Woolsey

Jonathan Tran

Syed-Muhammad Zaidi

Thuy Tran

We Invite You To Join Us For


Joint Annual Conference & Trade Show Sept. 7–10, 2017 Marriott St. Louis Grand Registration is NOW OPEN! Register at ipha.org/am-2017

Make Overnight Accommodations TODAY! Marriott St. Louis Grand 800 Washington Avenue St. Louis, MO 63101 314-621-9600



Congratulations to the 2017 graduates from the SIUE School of Pharmacy Morgan Atwood

Sarah Joachim

Dana Rod

San Baban

Jessica Johnson

Kelsey Salmon (Norris)

Redir Barwari

Thomas Kelly

Kayla Schell

Ashley Beiser

Regan Kitchens

Julie Schilling

Emily Benvenuto

Yasmyn Knight

Lindsay Schroeder

Danielle Bozzardi

Tracy Knobelock

Adam Schulte

Whitney Breweur (Maher)

Ali Koerper

Scott Sexton

Abigail Buchman

Andrew Korte

Amber Simmons

Ashley Buettner

Kelly Korza

Jordan Sinclair

Brian Burmeister

Kaycilee Legate

Chloe Stason

Jerry Chapman

Jessica Lorenson

Jacob Stason

Andrew Cloninger

Zachary Madej

Joshua Strange

Caleb Corrigan

Ashley Marchello

Emma Summers

Amber Crouch

Kristen Meiners

Brandon Taylor

Tyler Daugherty

Shelley Monroe (Smith)

David Taylor

Ashlen Dunn

Stephanie Mormino

Austin Tjaden

Matthew Ehrhardt

Brianna Nichols

Sarah Wagner

Janet Ellis

Katherine Olson

Rachel Webb

Kathryn Elzerman

Timothy Oyer

Lydia Weidner

Sarah Fox

Brock Pontious

Clayton Whittington

Christian Harrelson

Amy Probst

Rachel Wiechert

Chunhua Huang

Hannah Randall

Taylor Yuhas

Brandy Hudgins

Brayton Regner

Haley Ilcewicz

Zachary Righter

James Jirus

Kelsey Robertson



Career Safeguard At Pharmacists Mutual Insurance Company, we protect not only your pharmacy, but you as well. You’re covered no matter where your job takes you, with $1 million per occurrence and as much as $3 million aggregate. In our recent study, we found that 75% of claims were related to wrong drug or wrong dose – even with protocols in place. We know mistakes happen. But you’ve invested too much to become a pharmacist, and now’s the time to help safeguard that investment by purchasing professional liability insurance coverage. Call us today at 800.247.5930 for more information or apply online at phmic.com.

phmic.com Not licensed to sell all products in all states.

Harris-Stowe State University and St. Louis College Of Pharmacy Launch New Dual Degree Program Pier Scott

St. Louis, MO (Feb. 17, 2016) — Harris-Stowe State University (HSSU) and St. Louis College of Pharmacy (the College) announce the formation of a new program to provide educational opportunities for students in the field of pharmacy. The dual degree program will allow students to pursue a Doctor of Pharmacy degree in a 3+4 format. Students will complete three years of study in the Biology/Pre-Pharmacy track at Harris-Stowe and in their fourth year, they will begin work on their Doctor of Pharmacy at the College. The institutions celebrated the agreement in a formal signing ceremony today in the new Academic and Research Building on the St. Louis College of Pharmacy campus. “This partnership with St. Louis College of Pharmacy will allow our students the chance to enter an exciting health care career with tremendous employment potential,” said Dr. Dwaun J. Warmack, president, Harris-Stowe State University. “Today’s students realize that pharmacists work alongside physicians on health care teams and play a vital role in improving their patients’ overall health and wellbeing.” 50

Over the next decade, more Americans are expected to seek health services due to the aging population, and the Bureau of Labor Statistics projects employment in health care occupations is projected to grow 19 percent between 2014 and 2024. In the recently released report: “African Americans: College Majors and Earnings,” African Americans who chose pharmacy careers with a bachelor’s level degree saw the highest median annual earnings, at around $84,000. Earning potential is even higher with a Doctor of Pharmacy degree: according to the Bureau of Labor Statistics, the 2014 median salary for pharmacists was $120,950. “We take a lot of pride in making St. Louis College of Pharmacy a supportive and enriching environment for growth,” says Dr. John A. Pieper, president, St. Louis College of Pharmacy. “To live that mission, we are always looking to create as many opportunities as possible for students interested in pursuing a rewarding career as a pharmacist.” According to the American Association of Colleges of Pharmacy, of the total number

of students enrolled in first professional degree programs for fall 2014, 61.4 percent were women and 12.4 percent were underrepresented minority students. Administrators at HSSU and the College recognize this collaboration as an inventive and necessary opportunity for the institutions to increase the number of underrepresented students in this field. Dr. Dwaun Warmack, president of Harris-Stowe and Dr. John A. Pieper, president, St. Louis College of Pharmacy signed the agreement surrounded by faculty, staff and Harris-Stowe students interested in the program. Representing HSSU were Dr. Dwyane Smith, provost and vice president for academic affairs, Dr. Michelle McClure, associate provost, Dr. Jon Corbett, chair for the Department of Mathematics and Natural Science, Dr. Jana Marcette, assistant professor of biology, Dr. Sandra Leal, assistant professor of biology, and Dr. Tommie Turner, director of the Math and Science Academy. Also representing the College was Dr. Bruce Canaday, dean of the School of Pharmacy, and Dr. Brenda Gleason, associate dean for academic affairs.


To be eligible to enter the first professional year of the Doctor of Pharmacy program, HSSU students must complete all prerequisite courses by the end of their junior year. The student must also hold a cumulative GPA of at least 2.7, hold no individual course grades below a C- in prerequisite courses, successfully complete an in-person interview and writing assessment, and taken the Pharmacy College Admission Test. These requirements are the same as any student applying to transfer into the College’s professional program. Students who successfully complete four years of study in the dual-degree program will earn a Bachelor of Science in Biology with a Pre-Pharmacy minor from HSSU. They will earn a Doctor of Pharmacy degree from the College after completing the remaining professional program coursework and progression requirements. Coursework in the first three years of the program will primarily be held on the HSSU campus. In their sophomore year, students will take eight credit hours of organic chemistry on the College’s campus. In their junior year, they will take four credit hours of physics and three credit hours of health care communications on the College’s campus. HSSU students will be eligible to enter the program as early as this fall.

About Harris-Stowe State University

Harris-Stowe State University (HSSU), located in midtown St. Louis, is a fully accredited four-year institution that offers 31 majors, minors and certificate programs

in education, business and arts & sciences. In 2014, HSSU ranked No. 1 in the state of Missouri and No. 47 in the nation in granting degrees in mathematics and statistics to African Americans according to Missouri Department of Higher Education and Diverse: Issues In Higher Education, a news magazine that has ranked institutions conferring the most degrees to minority students for the past 30 years. Harris-Stowe also ranked No. 28 among the 2016 Top HBCUs in the country according to Niche, an online content provider of reviews and insight on more than 1,100 colleges nationwide. The University, which has origins dating back to 1857, offers the most affordable bachelor’s degree in the state of Missouri.

About St. Louis College of Pharmacy

For more than 150 years, St. Louis College of Pharmacy has been committed to educating the best pharmacists in the United States. The region’s only independent college of pharmacy, St. Louis College of Pharmacy is the third oldest continuously operating and 10th largest college of pharmacy in America. The student body is comprised of nearly 1,400 students from 32 states and 10 countries. The College admits students directly from high school and accepts transfer students and graduates from other colleges and universities in the sophomore and junior years of the undergraduate program and the first year of the professional program. Students earn a Doctor of Pharmacy (Pharm.D.) with an integrated Bachelor of Science degree in a seven-year curriculum. ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

ADVERTISE HERE ¼ page, ½ page, & full page ads available. Reach up to 15,000 pharmacists. Also ASK US about advertising on our website and in our monthly newsletter. Call Erica Burris at 217-522-7300

An education at the College opens up the world to graduates for a career in a wide range of practice settings. Graduates have a 100 percent job placement rate. The campus is transforming to better fit the needs of students, faculty, and staff. This summer, a new six-story, 213,000-square-foot, state-of-theart academic and research building opened. Construction is underway for a seven-story student center, residence hall, and recreation facility scheduled for completion in December 2016. When not in class, students can participate in more than 60 organizations, fraternities, intramurals, and sports. The College competes in 12 NAIA Division I sports. College alumni practice throughout the nation and in 14 different countries, providing a strong network to assist students with their goals. Additional information is available at stlcop.edu. 51



This series, Pharmacy and the Law, is presented by Pharmacists Mutual Insurance Company and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community.

CYBERSECURITY By Don. R. McGuire Jr., R.Ph., J.D.

Cybersecurity continues to make the news and to be a source of concern for all business owners. The recent WannaCry ransomware attack affected companies and governments in more than 150 countries. Data breaches and cyberattacks also occur in healthcare. In Rhode Island, the car of an employee of the state’s largest health network was broken into and a laptop was stolen. The laptop contained sensitive information on about 20,000 of the network’s patients. A healthcare provider in Texas had an unencrypted hard drive stolen. The hard drive contained information (e.g., social security numbers, dates of birth, driver license numbers, insurance information, etc.) about its patients going back to 2009. It is critical for pharmacies to assess their data security and take steps to strengthen it. Stronger regulations are sure to come, but improvements to your data security now will minimize the chances that your pharmacy ends up as your community’s lead news story. As an example, the New York Department of Financial Services recently promulgated new rules for cybersecurity of financial institutions.1 This includes 52

banks, insurance companies, and other financial services institutions. It does not apply to health care organizations or entities. The regulations contain 15 requirements for a cybersecurity

program. This article will not review all of them, but will address some that apply to the situations we have already seen. The regulations require penetration testing and vulnerability assessments. This would mean at least annual testing of firewalls and other portions of the overall cybersecurity program. This should alert you to any shortcomings in

your security and give you the opportunity to remedy them before an incident occurs. Also required is training and monitoring for your system’s users. Training is an integral part of a security program because a leading cause of data breaches is the people using the system. Phishing attacks and similar techniques succeed because they fool a user into allowing unauthorized access to the pharmacy’s data. Encryption is another important tool and New York’s regulation is going to require it. The regulation requires that data be encrypted both while being transmitted (such as by e-mail) and also while resting on hard drive. This requirement would help secure data that is physically taken, such as in the stolen laptop or server examples. Many people think to encrypt data while it is in transit, but steps should also be taken while it is being stored. The regulation also requires that organizations periodically dispose of sensitive information no longer needed for business operations. This will require the organization to assess the need to retain sensitive


information and then follow their own policies and procedures to securely dispose of unneeded information. This action may have mitigated the damage done when the hard drive containing seven years of data was stolen in Texas. The world continues to move toward more virtual and digital realms, so these challenges are not going away. Dealing with data breaches is expensive. Some studies estimate around $200 per record affected. For the data

of those 20,000 patients on the laptop, this equates to around $4 million. And this doesn’t take into account your reputational damage. The pharmacist-patient relationship is built on trust and data breaches will seriously damage these relationships. Ransomware can also be devastating to your pharmacy. Having your system held hostage until you pay the ransom (or can re-construct your system from back-ups) will, at a minimum, inconvenience your patients. It may cause them to question whether

they should share their personal information with you. There is no reason to wait for a law or regulation to be passed before shoring up your data security. You are already holding sensitive patient information and there are already numerous threats out there in cyberspace. A cyber incident can cause significant financial and reputational damage to your practice. This is not the time to take an ostrich approach to your data security.

© Don R. McGuire Jr., R.Ph., J.D., is General Counsel, Senior Vice President, Risk Management & Compliance at Pharmacists Mutual Insurance Company.

This article discusses general principles of law and risk management. It is not intended as legal advice. Pharmacists should consult their own attorneys and insurance companies for specific advice. Pharmacists should be familiar with policies and procedures of their employers and insurance companies, and act accordingly. 1

23 NYCRR 500.00 to 500.23




Pledge Form I wish to support the IPhA Foundation goal of providing support in the form of grants, scholarships, and professional expertise for pharmacist delivered patient care initiatives designed to optimize patient health outcomes, student participation in IPhA activities, and the preservation and promotion of the history of pharmacy in Illinois. q A single contribution of: $ __________ q Please charge my credit card $___________ for 1 year. q Please charge my credit card $___________ until I notify otherwise. Total Pledge Amount: $ __________

Contribution Details q My check is enclosed (Payable to IPhA Foundation) q Please charge my: m Visa m MC m AmEx Name on card: _________________________________________ Card #: _______________________________________________

(Used to determine donor level) Presidential Level: $5000+ Executive Level: $1000+ Director Level: $250 - $999 Sponsor Level: $100 - $249

First: _______________ MI: ___ Last: ______________________ Is this your: q Home q Business/Organization Bus/Org: ______________________________________________ Street: ________________________________________________ City: _____________________ State: ____ Zip: ____________ H-Phone: _______________ B-Phone: ______________________ Email: ________________________________________________

Donor Level: up to $99 Student Level: $10

Signature: _____________________________________________ Expiration Date: ____________________ CVV: _______________ Send To

Contributions to the IPhA Foundation, a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code, are deductible for computing income and estate taxes.

IPhA Foundation 204 West Cook Street Springfield IL 62704-2526

Fax: (217) 522-7349

Thank you to the following 2nd Quarter 2017 Foundation Donors Director Level ($250 — $999) Tony Budde Starlin Haydon-Greatting Randy Malan Cindy Mende-Russell Harry Zollars


Sponsor Level ($100 — $249) Eric Bandy Tim Gleason Michelle Habbal Gary Moreland John Quinett Garth Reynolds Nicholas Tillman

Donor Level (up to $99) Tim Lawson Gary Bandy Valerie Lawson Thomas Beverly Jonathon Lehan Wesley Breeze Laura Licari Rodney Brent Rupesh Manek Mickie Brunner John Metzger Fred Calcaterra Miriam Mobley Smith Beaux Cole Henry Paetsch Gary Frisch William Zachary Parker Paul Giannetto Bernard Scavella John Groesback Judith Sommers Hanson Bill Jerrels Bruce Stout Donald Johnston Michael Swiersz Chungja Jung Darryl Tjaden Steve Karagiannis Terry Traster Carl Kasiar Roseann Van Duren Jessica Kerr John Velk Kenneth Kinsinger Emily Wetherholt Brant Kitto Jill Woodward Janice Kleppe


Contact Information

Name: _____________________________________________________________________ Street Address: ______________________________________________________________ City: _________________________________ State: ________ Zip+4: ______________ Senate District Number: _________________

House District Number: ________________

Phone: ______________________ Email: ________________________________________ Yes, I want to invest in the future of pharmacy in Illinois!

The Illinois Pharmacists Political Action Committee (IPPAC) is a voluntary non-profit unincorporated committee of Pharmacists with an interest in the election of qualified state (and local) candidates to public office and to further the interests of Pharmacy in the State of Illinois

m Enclosed is my single contribution of: q $5,000 q $2,000 q $1,000 q $500 q $250 q $100 q $50 q Other $_________ m I would like to contribute on a monthly basis until I notify IPhA to discontinue. Please charge my credit card $______ on the 15th of each month. m I would like to contribute on a monthly basis for one year: Please charge my credit card $______ on the 15th of each month. Payment Information

q My check payable to IPPAC is enclosed q Please charge my: m Visa m MC

Political contributions are not tax deductible. A copy of our report filed with the State Board of Elections is (or will be) available for purchase from the State Board of Elections, Springfield, IL.

m AmEx

Card Number: __________________________________

Expiration Date: _________________ CVV: _________ Signature: _____________________________________ Date: _________________________________________

Mail To IPPAC 204 West Cook Street Springfield, IL 62704-2526 Fax To (217) 522-7349 For More Information (217) 522-7300

Thank you to the following 2nd Quarter 2017 PAC Contributors Gary Bandy Thomas Beverly Wesley Breeze Rodney Brent Fred Calcaterra Beaux Cole Julie Eggerman Cynthia Gelsthorpe Paul Giannetto John Groesbeck Michelle Habbal Michelle Habbal Bill Jerrels Donald Johnston Chungja Jung Steve Karagiannis Jason Kasiar

Carl Kasiar Jay Kim Kenneth Kinsinger Brant Kitto Janice Kleppe Valerie Lawson Timothy Lawson Jonathon Lehan Rupesh Manek John Maxwell John Maxwell Gordon Mazzotti John Metzger Mike Minesinger Miriam Mobley Smith Gary Moreland Garry Moreland ILLINOIS PHARMACISTS ASSOCIATION • WWW.IPHA.ORG

Henry Paetsch William Zachary Parker Ramesh Patel Garth Reynolds Bernard Scavella Sommers Judith Hanson Bruce Stout Michael Swiersz Nicholas Tillman Darryl Tjaden Terry Traster John Velk Anita Wear Kevin Winston Jill Woodward


Mistakes can happen. Don’t put your pharmacy at risk. M A K E YOU R PATIENTS A N D YOU R P HAR MACY SAFER .


Increase patient safety – learn from collected safety data and online resources Maintain compliance – meet accreditation, credentialing, PBM and state QA requirements Reduce costs – increase operations efficiency, reduce potential risk and cut down on “re-do” Rxs Safeguard your data – Patient Safety Organizations offer confidentiality and legal protection

Learn more at www.medicationsafety.org or call us at (866) 365-7472. The Alliance of Medication Safety (APMS) is a federally listed Patient Safety Organization (PSO).